TW202112738A - Compound, composition, film, laminate, and display device - Google Patents

Compound, composition, film, laminate, and display device Download PDF

Info

Publication number
TW202112738A
TW202112738A TW109124436A TW109124436A TW202112738A TW 202112738 A TW202112738 A TW 202112738A TW 109124436 A TW109124436 A TW 109124436A TW 109124436 A TW109124436 A TW 109124436A TW 202112738 A TW202112738 A TW 202112738A
Authority
TW
Taiwan
Prior art keywords
compound
group
formula
liquid crystal
mmol
Prior art date
Application number
TW109124436A
Other languages
Chinese (zh)
Inventor
高橋京佑
Original Assignee
日商住友化學股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商住友化學股份有限公司 filed Critical 日商住友化學股份有限公司
Publication of TW202112738A publication Critical patent/TW202112738A/en

Links

Abstract

A compound represented by formula (1). In the formula, Ar1, Ar2, and Ar3 represent a 1,4-phenylene group or an optionally substituted divalent sulfur-containing aromatic heterocyclic group, and at least one of Ar1 and Ar2 has a fluorine atom as a substituent. n represents 1 or 2. R1 represents a single bond or a group selected from the group consisting of -OC(=O)-, -C(=O)O-, -C≡C-, -CH=CH-, -CH=N-, and -N=CH-. R2 represents an alkylamino group or an alkoxy group. R3 represents a group selected from the group consisting of alkanediyl groups, alkanediyloxy groups, alkanediyloxycarbonyl groups, and alkanediylcarbonyloxy groups. R4 represents a polymerizable group or a hydrogen atom. R4-R3-Ar1-(-R1-Ar2-)n-N=N-Ar3-R2 (1).

Description

化合物、組合物、膜、積層體及顯示裝置Compound, composition, film, laminate and display device

本發明係關於一種化合物、組合物、膜、積層體及顯示裝置。The present invention relates to a compound, composition, film, laminate and display device.

對於圖像顯示面板等顯示器有繼續薄型化之要求,對作為其構成要素之一之偏光板、偏光元件等亦要求進一步薄型化。對於此種要求,例如提出有一種薄型之主客(host-guest)型偏光元件,其具備包含聚合性液晶化合物及呈二色性之色素化合物之偏光膜(例如,參照專利文獻1及2)。 [先前技術文獻] [專利文獻]There is a demand for continued thinning of displays such as image display panels, and further thinning is also required for polarizing plates and polarizing elements, which are one of its constituent elements. In response to this requirement, for example, a thin host-guest type polarizing element is proposed, which includes a polarizing film containing a polymerizable liquid crystal compound and a dichroic dye compound (for example, refer to Patent Documents 1 and 2). [Prior Technical Literature] [Patent Literature]

[專利文獻1]日本專利特表2007-510946號公報 [專利文獻2]日本專利特開2013-37353號公報[Patent Document 1] Japanese Patent Publication No. 2007-510946 [Patent Document 2] Japanese Patent Laid-Open No. 2013-37353

[發明所欲解決之問題][The problem to be solved by the invention]

然而,若於製造偏光元件所具備之偏光膜之步驟中使用紫外線(UV)曝光,則有時色素化合物會改性,因此存在加工製程受到限制之情形。However, if ultraviolet (UV) exposure is used in the step of manufacturing the polarizing film provided in the polarizing element, the pigment compound may be modified in some cases, so the processing process may be restricted.

本發明之目的在於提供一種紫外線(UV)耐久性較高之色素化合物。 [解決問題之技術手段]The object of the present invention is to provide a pigment compound with high ultraviolet (UV) durability. [Technical means to solve the problem]

本發明提供下述[1]至[9]。 [1]一種化合物,其以下述式(1)表示。 R4 -R3 -Ar1 -(-R1 -Ar2 -)n -N=N-Ar3 -R2 (1) [式(1)中,Ar1 、Ar2 及Ar3 分別獨立地表示可具有取代基之1,4-伸苯基或可具有取代基之2價含硫芳香族雜環基,Ar1 及Ar2 之至少一者具有氟原子作為取代基;n表示1或2之整數;R1 表示單鍵、或選自由-OC(=O)-、-C(=O)O-、-C≡C-、-CH=CH-、-CH=N-及-N=CH-所組成之群中之至少1種基;R2 表示可具有聚合性基之烷基胺基、或可具有聚合性基之烷氧基;R3 表示選自由碳數4至20之烷二基、碳數2至20之烷二基氧基、碳數2至20之烷二基氧基羰基及碳數2至20之烷二基羰氧基所組成之群中之至少1種基;R4 表示聚合性基或氫原子;於n為2之情形時,2個R1 可相同亦可不同,2個Ar2 可相同亦可不同]。 [2]如[1]中記載之化合物,其中上述式(1)中,Ar1 及Ar2 之任一者具有1個或2個氟原子作為取代基。 [3]如[1]或[2]中記載之化合物,其中上述式(1)中,R1 為單鍵。 [4]如[1]至[3]中任一項中記載之化合物,其中上述式(1)中,n為1之整數。 [5]如[1]至[4]中任一項中記載之化合物,其中上述聚合性基為自由基聚合性基。 [6]一種組合物,其包含如[1]至[5]中任一項中記載之化合物。 [7]一種膜,其以如[1]至[5]中任一項中記載之化合物作為形成材料。 [8]一種積層體,其包含如[7]中記載之膜。 [9]一種顯示裝置,其具備如[7]中記載之膜。 [發明之效果]The present invention provides the following [1] to [9]. [1] A compound represented by the following formula (1). R 4 -R 3 -Ar 1 -(-R 1 -Ar 2 -) n -N=N-Ar 3 -R 2 (1) [In formula (1), Ar 1 , Ar 2 and Ar 3 are each independently Represents a 1,4-phenylene group which may have a substituent or a divalent sulfur-containing aromatic heterocyclic group which may have a substituent , at least one of Ar 1 and Ar 2 has a fluorine atom as a substituent; n represents 1 or 2 R 1 represents a single bond, or is selected from -OC(=O)-, -C(=O)O-, -C≡C-, -CH=CH-, -CH=N- and -N= At least one group in the group consisting of CH-; R 2 represents an alkylamino group that may have a polymerizable group or an alkoxy group that may have a polymerizable group; R 3 represents an alkyl group selected from 4 to 20 carbon atoms At least one group in the group consisting of a diyl group, alkanediyloxy group with 2 to 20 carbons, alkanediyloxycarbonyl group with 2 to 20 carbons, and alkanediylcarbonyloxy group with 2 to 20 carbons ; R 4 represents a polymerizable group or a hydrogen atom; when n is 2, two R 1 may be the same or different, and two Ar 2 may be the same or different]. [2] The compound as described in [1], wherein in the above formula (1), any one of Ar 1 and Ar 2 has one or two fluorine atoms as a substituent. [3] The compound as described in [1] or [2], wherein in the above formula (1), R 1 is a single bond. [4] The compound as described in any one of [1] to [3], wherein in the above formula (1), n is an integer of 1. [5] The compound as described in any one of [1] to [4], wherein the polymerizable group is a radical polymerizable group. [6] A composition comprising the compound as described in any one of [1] to [5]. [7] A film using the compound as described in any one of [1] to [5] as a forming material. [8] A laminate comprising the film as described in [7]. [9] A display device including the film described in [7]. [Effects of Invention]

根據本發明,能夠提供一種紫外線耐久性較高之色素化合物。According to the present invention, it is possible to provide a pigment compound with high ultraviolet durability.

於本說明書中,術語「步驟」不僅包括獨立之步驟,而且即便於無法與其他步驟明確地區別之情形時,只要可達成該步驟之預期目的,則亦包含於本用語中。又,關於組合物中之各成分之含量,於組合物中存在複數種屬於各成分之物質之情形時,只要未特別說明,則意指組合物中所存在之該複數種物質之合計量。以下,針對本發明之實施方式詳細地進行說明。再者,本發明之範圍並不限定於此處所說明之實施方式,可於無損本發明之主旨之範圍內進行各種變更。In this specification, the term "step" not only includes an independent step, but even when it cannot be clearly distinguished from other steps, as long as the intended purpose of the step can be achieved, it is also included in this term. In addition, regarding the content of each component in the composition, when there are multiple substances belonging to each component in the composition, unless otherwise specified, it means the total amount of the multiple substances present in the composition. Hereinafter, embodiments of the present invention will be described in detail. In addition, the scope of the present invention is not limited to the embodiments described here, and various changes can be made without detracting from the gist of the present invention.

<化合物> 本實施方式之化合物係可作為色素而利用之化合物,具有下述式(1)所表示之結構。 R4 -R3 -Ar1 -(-R1 -Ar2 -)n -N=N-Ar3 -R2 (1)<Compound> The compound of the present embodiment is a compound that can be used as a dye, and has a structure represented by the following formula (1). R 4 -R 3 -Ar 1 -(-R 1 -Ar 2 -) n -N=N-Ar 3 -R 2 (1)

式(1)中,較佳為n表示1或2之整數,且n為1。式(1)中之偶氮基之幾何異構為順式及反式之任一者均可,較佳為反式。In formula (1), it is preferable that n represents an integer of 1 or 2, and n is 1. The geometric isomerism of the azo group in the formula (1) may be either cis or trans, preferably trans.

式(1)中之Ar1 、Ar2 及Ar3 相互獨立地表示可具有取代基之1,4-伸苯基或可具有取代基之2價含硫芳香族雜環基。 Ar 1 , Ar 2 and Ar 3 in the formula (1) independently represent a 1,4-phenylene group which may have a substituent or a divalent sulfur-containing aromatic heterocyclic group which may have a substituent.

作為Ar1 、Ar2 及Ar3 中之取代基,可列舉:甲基、乙基及丁基等碳數1至10之烷基;甲氧基、乙氧基及丁氧基等碳數1至10之烷氧基;三氟甲基等碳數1至10之氟化烷基;氰基;硝基;氯原子、氟原子等鹵素原子;胺基、二乙基胺基及吡咯啶基等取代或未經取代胺基。此處,取代胺基意指於氮原子上具有1個或2個碳數1至10之烷基之胺基、或者氮原子上之2個烷基相互鍵結而形成有碳數2至8之烷二基之胺基。又,未經取代胺基為-NH2 。再者,作為碳數1至10之烷基,可列舉:甲基、乙基、己基等。作為碳數2至8之烷二基,可列舉:伸乙基、丙烷-1,3-二基、丁烷-1,3-二基、丁烷-1,4-二基、戊烷-1,5-二基、己烷-1,6-二基、庚烷-1,7-二基、辛烷-1,8-二基等。Examples of the substituents in Ar 1 , Ar 2 and Ar 3 include alkyl groups having 1 to 10 carbon atoms such as methyl, ethyl, and butyl; and carbon numbers 1 such as methoxy, ethoxy, and butoxy. Alkoxy group to 10; fluorinated alkyl group with carbon number 1 to 10 such as trifluoromethyl group; cyano group; nitro group; halogen atom such as chlorine atom and fluorine atom; amino group, diethylamino group and pyrrolidinyl group Etc. substituted or unsubstituted amine groups. Here, a substituted amino group means an amino group having one or two alkyl groups having 1 to 10 carbon atoms on the nitrogen atom, or two alkyl groups on the nitrogen atom are bonded to each other to form a carbon number 2 to 8 The amine group of the alkanediyl group. In addition, the unsubstituted amino group is -NH 2 . Furthermore, examples of the alkyl group having 1 to 10 carbon atoms include a methyl group, an ethyl group, a hexyl group, and the like. Examples of alkanediyl groups having 2 to 8 carbon atoms include ethylene, propane-1,3-diyl, butane-1,3-diyl, butane-1,4-diyl, and pentane- 1,5-diyl, hexane-1,6-diyl, heptane-1,7-diyl, octane-1,8-diyl, etc.

本實施方式之化合物之Ar1 及Ar2 之至少一者具有氟原子作為取代基。Ar1 及Ar2 所具有之氟原子之總數較佳為1個以上4個以下,更佳為1個或2個,進而較佳為1個。較佳為Ar1 及Ar2 中之任一者具有氟原子作為取代基。較佳為Ar1 及Ar2 中之任一者具有1個以上4個以下氟原子,更佳為具有1個或2個氟原子,進而較佳為具有1個氟原子。 At least one of Ar 1 and Ar 2 of the compound of this embodiment has a fluorine atom as a substituent. The total number of fluorine atoms possessed by Ar 1 and Ar 2 is preferably 1 or more and 4 or less, more preferably 1 or 2, and still more preferably 1. It is preferable that any one of Ar 1 and Ar 2 has a fluorine atom as a substituent. It is preferable that any one of Ar 1 and Ar 2 has 1 to 4 fluorine atoms, more preferably 1 or 2 fluorine atoms, and still more preferably 1 fluorine atom.

式(1)所表示之化合物藉由Ar1 及Ar2 之至少一者具有氟原子作為取代基,能夠表現出優異之紫外線耐久性。藉此,於具備以式(1)所表示之化合物作為形成材料而構成之膜之偏光板之製造步驟中,即便使用紫外線曝光亦可抑制所製造之偏光板之特性降低,從而能夠擴大製造製程之選項。此處,色素化合物之紫外線耐久性例如可根據由色素化合物所形成之膜之紫外線照射前後之吸光度之維持率進行評價。例如,3000 mJ/cm2 之UV照射前後之色素化合物之吸光度之維持率為80%以上、85%以上、或90%以上。The compound represented by the formula (1) has a fluorine atom as a substituent at least one of Ar 1 and Ar 2 and can exhibit excellent ultraviolet durability. Thereby, in the manufacturing step of the polarizing plate provided with the film composed of the compound represented by the formula (1) as the forming material, even if the ultraviolet exposure is used, the characteristics of the manufactured polarizing plate can be suppressed from degrading, and the manufacturing process can be expanded的options. Here, the ultraviolet durability of the dye compound can be evaluated based on the retention of absorbance before and after ultraviolet irradiation of the film formed of the dye compound, for example. For example, the retention rate of the absorbance of the pigment compound before and after UV irradiation at 3000 mJ/cm 2 is 80% or more, 85% or more, or 90% or more.

作為Ar1 、Ar2 及Ar3 所具有之除氟原子以外之取代基,較佳為甲基或者甲氧基。藉此,式(1)所表示之化合物更容易被包含於如層列型液晶之高秩序液晶結構中。又,作為Ar1 、Ar2 及Ar3 所具有之除氟原子以外之取代基之數,較佳為1個或2個。藉此,式(1)所表示之化合物更容易被包含於如層列型液晶之高秩序液晶結構中。The substituent other than the fluorine atom possessed by Ar 1 , Ar 2 and Ar 3 is preferably a methyl group or a methoxy group. Thereby, the compound represented by formula (1) is easier to be included in a high-order liquid crystal structure such as smectic liquid crystal. In addition, the number of substituents other than the fluorine atom possessed by Ar 1 , Ar 2 and Ar 3 is preferably one or two. Thereby, the compound represented by formula (1) is easier to be included in a high-order liquid crystal structure such as smectic liquid crystal.

又,於n為1之情形時,就具有分子合成之簡便性及高性能之兩者之方面而言,較佳為Ar1 、Ar2 及Ar3 之中至少2個為1,4-伸苯基。In addition, when n is 1, it is preferable that at least two of Ar 1 , Ar 2 and Ar 3 are 1,4-stretched in terms of the simplicity of molecular synthesis and high performance. Phenyl.

作為Ar1 、Ar2 及Ar3 中之2價含硫芳香族雜環基,可列舉:自選自由噻吩、苯并噻吩、二苯并噻吩、苯并二噻吩、噻吩并呋喃、噻吩并噻吩、呋喃并噻唑、噻吩并噻唑、及苯并噻唑所組成之群之含硫芳香族雜環化合物除去2個氫原子而形成的基。Examples of the divalent sulfur-containing aromatic heterocyclic group in Ar 1 , Ar 2 and Ar 3 include: selected from thiophene, benzothiophene, dibenzothiophene, benzodithiophene, thienofuran, thienothiophene, The sulfur-containing aromatic heterocyclic compound of the group consisting of furanothiazole, thienothiazole, and benzothiazole is a group formed by removing two hydrogen atoms.

於本實施方式之化合物包含2價含硫芳香族雜環基與1,4-伸苯基直接鍵結而成之結構之情形時,包含該化合物之膜之二色比提昇。進而,包含該化合物之膜於UV曝光前後進行比較時之二色比之維持率較高。When the compound of the present embodiment includes a structure in which a divalent sulfur-containing aromatic heterocyclic group and 1,4-phenylene are directly bonded, the two-color ratio of the film including the compound is improved. Furthermore, the film containing the compound has a higher maintenance rate of the dichroic ratio when compared before and after UV exposure.

R1 表示單鍵、或選自由-OC(=O)-、-C(=O)O-、-C≡C-、-CH=CH-、-CH=N-及-NH=C-所組成之群中之至少1種連結基。於存在複數個R1 之情形時,可分別相同亦可不同。R較佳為單鍵、-OC(=O)-、或-C(=O)O-,更佳為單鍵。R 1 represents a single bond, or is selected from -OC(=O)-, -C(=O)O-, -C≡C-, -CH=CH-, -CH=N- and -NH=C- At least one linking group in the group consisting of. When there are a plurality of R 1 , they may be the same or different. R is preferably a single bond, -OC(=O)-, or -C(=O)O-, more preferably a single bond.

R2 表示可具有聚合性基之烷基胺基、或可具有聚合性基之烷氧基。作為R2 中之聚合性基,較佳為自由基聚合性基,例如可列舉(甲基)丙烯酸酯基((甲基)丙烯醯氧基)、苯乙烯基(乙烯基苯基)等自由基聚合性基,其中,較佳為(甲基)丙烯酸酯基。於R2 具有聚合性基之情形時,其數例如為1個或2個,較佳為1個。R 2 represents an alkylamino group which may have a polymerizable group, or an alkoxy group which may have a polymerizable group. The polymerizable group in R 2 is preferably a radical polymerizable group, for example, a (meth)acrylate group ((meth)acryloyloxy group), a styryl group (vinylphenyl), etc. are free Among them, the polymerizable group is preferably a (meth)acrylate group. When R 2 has a polymerizable group, the number is, for example, one or two, preferably one.

作為R2 之烷基胺基,例如可列舉:氮原子上具有1個或2個碳數1至10之烷基之胺基、或者氮原子上之2個烷基相互鍵結而形成有碳數2至8之烷二基之環狀胺基。作為R2 之烷基胺基之具體例,可列舉:甲基胺基、乙基胺基、二甲胺基、二乙基胺基、二丙基胺基、甲基乙基胺基、甲基己基胺基、吡咯啶基、哌啶基、𠰌啉基等。R2 之烷基胺基較佳為選自由二甲胺基、二乙基胺基、二丙基胺基、甲基乙基胺基、及甲基己基胺基所組成之群中之至少1種。Examples of the alkylamino group of R 2 include: an amino group having one or two alkyl groups with a carbon number of 1 to 10 on the nitrogen atom, or two alkyl groups on the nitrogen atom are bonded to each other to form a carbon A cyclic amine group of an alkanediyl group of 2 to 8. Specific examples of the alkylamino group of R 2 include: methylamino, ethylamino, dimethylamino, diethylamino, dipropylamino, methylethylamino, methyl Hexylamino, pyrrolidinyl, piperidinyl, linolinyl and the like. The alkylamino group of R 2 is preferably at least 1 selected from the group consisting of dimethylamino, diethylamino, dipropylamino, methylethylamino, and methylhexylamino Kind.

作為R2 之烷氧基,例如可列舉碳數1至10之烷氧基。作為R2 之烷氧基之具體例,可列舉:甲氧基、乙氧基、丙氧基、丁氧基、戊氧基、己氧基、環戊氧基、環己氧基等。R2 之烷氧基較佳為選自由乙氧基、丙氧基等所組成之群中之至少1種。Examples of the alkoxy group of R 2 include alkoxy groups having 1 to 10 carbon atoms. Specific examples of the alkoxy group of R 2 include a methoxy group, an ethoxy group, a propoxy group, a butoxy group, a pentyloxy group, a hexyloxy group, a cyclopentyloxy group, a cyclohexyloxy group, and the like. The alkoxy group of R 2 is preferably at least one selected from the group consisting of ethoxy and propoxy.

式(1)中之R3 表示選自由碳數4至20之烷二基、碳數2至20之烷二基氧基、碳數2至20之烷二基氧基羰基及碳數2至20之烷二基羰氧基所組成之群中之至少1種2價基。 R 3 in formula (1) represents selected from the group consisting of alkanediyl groups having 4 to 20 carbon atoms, alkanediyloxy groups having 2 to 20 carbon atoms, alkanediyloxycarbonyl groups having 2 to 20 carbon atoms, and alkanediyloxycarbonyl groups having 2 to 20 carbon atoms. At least one divalent group in the group consisting of 20 alkanediylcarbonyloxy groups.

作為碳數4至20之烷二基,可列舉自正丁基、異丁基、第三丁基、正戊基、異戊基、新戊基、正己基、正庚基、正辛基、正壬基、正癸基等未經取代(不具有取代基)之直鏈狀或支鏈狀之碳數4至20之烷基除去1個氫原子所形成之烷二基。烷二基之碳數較佳為4至16,更佳為4至12。Examples of alkanediyl groups having 4 to 20 carbon atoms include n-butyl, isobutyl, tertiary butyl, n-pentyl, isopentyl, neopentyl, n-hexyl, n-heptyl, n-octyl, An alkanediyl group formed by removing one hydrogen atom from an unsubstituted (unsubstituted) straight-chain or branched-chain alkyl group with 4 to 20 carbon atoms, such as n-nonyl and n-decyl. The carbon number of the alkanediyl group is preferably 4-16, more preferably 4-12.

構成上述碳數4至20之烷基之1個以上氫原子亦可經鹵素原子(例如氟原子)、羥基、胺基或取代胺基取代。此處,作為取代胺基,例如可列舉:N-甲基胺基、N-乙基胺基、N,N-二甲胺基、N,N-二乙基胺基等經1個或2個碳數1至20之烷基取代之胺基等。作為1個以上氫原子經鹵素原子、羥基、胺基等取代之烷基,可列舉:氟丁基、八氟丁基等碳數4至20之鹵烷基;羥丁基、羥戊基、羥己基等碳數4至20之羥烷基;胺基丁基、2-(N,N-二甲胺基)丁基等具有未經取代胺基或取代胺基之碳數4至20之烷基等。One or more hydrogen atoms constituting the aforementioned alkyl group having 4 to 20 carbon atoms may be substituted with a halogen atom (for example, a fluorine atom), a hydroxyl group, an amino group, or a substituted amino group. Here, as the substituted amino group, for example, N-methylamino group, N-ethylamino group, N,N-dimethylamino group, N,N-diethylamino group, etc. can be exemplified by 1 or 2 Amino groups substituted by an alkyl group with 1 to 20 carbon atoms, etc. Examples of alkyl groups in which one or more hydrogen atoms are substituted with halogen atoms, hydroxyl groups, amino groups, etc. include: fluorobutyl, octafluorobutyl, and other C4-20 haloalkyl groups; hydroxybutyl, hydroxypentyl, Hydroxyalkyl groups with 4 to 20 carbons such as hydroxyhexyl; aminobutyl and 2-(N,N-dimethylamino)butyl groups with unsubstituted or substituted amino groups with 4 to 20 carbons Alkyl and so on.

於構成上述烷基之碳原子間亦可插入-O-或-NR* -。此處,R* 表示氫原子或碳數1至6、較佳為碳數1至4之烷基,作為碳數1至6之烷基,可列舉:甲基、乙基、丁基、己基等。作為於碳原子間插入有-O-或-NR* -之烷基,可列舉:2-乙氧基乙基、2-(2-乙氧基乙氧基)乙基、2-[2-(乙基胺基)乙基)胺基]乙基等。 -O- or -NR* - may be inserted between the carbon atoms constituting the above-mentioned alkyl group. Here, R * represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, preferably 1 to 4 carbon atoms. Examples of the alkyl group having 1 to 6 carbon atoms include methyl, ethyl, butyl, and hexyl. Wait. Examples of the alkyl group with -O- or -NR * -inserted between carbon atoms include 2-ethoxyethyl, 2-(2-ethoxyethoxy)ethyl, 2-[2- (Ethylamino) ethyl) amino] ethyl and the like.

作為碳數2至20之烷二基氧基,可列舉自乙氧基、正丙氧基、異丙氧基、正丁氧基、異丁氧基、第三丁氧基、正戊氧基、異戊氧基、新戊氧基、正己氧基、正庚氧基、正辛氧基、正壬氧基、正癸氧基等未經取代之直鏈狀或支鏈狀之碳數2至20之烷氧基除去1個氫原子所形成之烷二基氧基。烷二基氧基之碳數較佳為2至16,更佳為2至12。Examples of alkanediyloxy groups having 2 to 20 carbon atoms include ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, tert-butoxy, and n-pentoxy. , Isopentyloxy, neopentyloxy, n-hexyloxy, n-heptyloxy, n-octyloxy, n-nonyloxy, n-decyloxy and other unsubstituted linear or branched carbon numbers 2 Alkyloxy group formed by removing 1 hydrogen atom from alkoxy group to 20. The carbon number of the alkanediyloxy group is preferably 2-16, more preferably 2-12.

構成碳數2至20之烷氧基之1個以上氫原子亦可經鹵素原子(例如氟原子)、羥基、胺基或取代基胺基取代。取代基胺基與上述相同。作為1個以上氫原子經鹵素原子、羥基、胺基等取代之烷氧基,可列舉:四氟乙氧基、八氟丁氧基等碳數2至20之鹵代烷氧基;2-羥基乙氧基等碳數2至20之羥基烷氧基;胺基乙氧基、2-(N,N-二甲胺基)乙氧基等具有未經取代胺基或取代基胺基之碳數2至20之烷氧基。One or more hydrogen atoms constituting the alkoxy group having 2 to 20 carbon atoms may be substituted with a halogen atom (for example, a fluorine atom), a hydroxyl group, an amino group, or a substituent amino group. The substituent amino group is the same as described above. Examples of alkoxy groups in which one or more hydrogen atoms are substituted by halogen atoms, hydroxyl groups, amino groups, etc. include: tetrafluoroethoxy, octafluorobutoxy and other halogenated alkoxy groups having 2 to 20 carbon atoms; 2-hydroxyethyl Hydroxy alkoxy with 2 to 20 carbons such as oxy; amino ethoxy, 2-(N,N-dimethylamino)ethoxy, etc. have unsubstituted amino or substituted amino groups with carbon number Alkoxy from 2 to 20.

於構成上述烷氧基之碳原子間亦可插入-O-或-NR* -。作為於碳原子間插入有-O-或-NR* -之烷氧基,可列舉:甲氧基甲氧基、2-乙氧基乙氧基、2-(2-乙氧基乙氧基)基等。再者,R* 如上所述。 -O- or -NR* - may be inserted between the carbon atoms constituting the above-mentioned alkoxy group. Examples of the alkoxy group with -O- or -NR * -inserted between carbon atoms include: methoxymethoxy, 2-ethoxyethoxy, and 2-(2-ethoxyethoxy ) Base and so on. Furthermore, R * is as described above.

作為碳數2至20之烷二基氧基羰基,可列舉自甲氧基羰基、乙氧基羰基、正丙氧基羰基、異丙氧基羰基、正丁氧基羰基、異丁氧基羰基、第三丁氧基羰基、正戊氧基羰基、異戊氧基羰基、新戊氧基羰基、正己氧基羰基、正庚氧基羰基、正辛氧基羰基、正壬氧基羰基、正癸氧基羰基等未經取代之碳數2至20之烷氧基羰基除去1個氫原子所形成之烷二基氧基羰基。烷二基氧基羰基之烷二基部分之碳數較佳為1至16,更佳為1至12。Examples of the alkanediyloxycarbonyl group having 2 to 20 carbon atoms include methoxycarbonyl, ethoxycarbonyl, n-propoxycarbonyl, isopropoxycarbonyl, n-butoxycarbonyl, and isobutoxycarbonyl. , Tertiary butoxycarbonyl, n-pentyloxycarbonyl, isopentyloxycarbonyl, neopentyloxycarbonyl, n-hexoxycarbonyl, n-heptoxycarbonyl, n-octyloxycarbonyl, n-nonyloxycarbonyl, n- An alkanediyloxycarbonyl group formed by removing one hydrogen atom from an unsubstituted alkoxycarbonyl group with 2 to 20 carbon atoms such as decyloxycarbonyl group. The carbon number of the alkanediyl part of the alkanediyloxycarbonyl group is preferably 1-16, more preferably 1-12.

構成碳數2至20之烷氧基羰基之1個以上氫原子亦可經鹵素原子(例如氟原子)、羥基、胺基或具有取代基之胺基取代。具有取代基之胺基與上述相同。作為1個以上氫原子經鹵素原子、羥基、胺基等取代之烷氧基羰基,可列舉:氟乙氧基羰基、三氟乙氧基羰基、四氟乙氧基羰基、八氟丁氧基羰基等碳數2至20之鹵代烷氧基羰基。One or more hydrogen atoms constituting the alkoxycarbonyl group having 2 to 20 carbon atoms may be substituted with a halogen atom (for example, a fluorine atom), a hydroxyl group, an amino group, or an amino group having a substituent. The amino group having a substituent is the same as above. Examples of alkoxycarbonyl groups in which one or more hydrogen atoms are substituted by halogen atoms, hydroxyl groups, amino groups, etc. include fluoroethoxycarbonyl, trifluoroethoxycarbonyl, tetrafluoroethoxycarbonyl, and octafluorobutoxy Carbon 2-20 halogenated alkoxycarbonyl groups such as carbonyl groups.

作為碳數2至20之烷二基羰氧基,可列舉自乙醯氧基、乙基羰氧基、正丙基羰氧基、異丙基羰氧基、正丁基羰氧基、異丁基羰氧基、第三丁基羰氧基、正戊基羰氧基、異戊基羰氧基、新戊基羰氧基、正己基羰氧基、正庚基羰氧基、正辛基羰氧基、正壬基羰氧基、正癸基羰氧基等未經取代之碳數2至20之烷醯氧基除去1個氫原子所形成之烷二基羰氧基。烷二基羰氧基之烷二基部分之碳數較佳為1至16,更佳為1至12。Examples of the alkanediylcarbonyloxy group having 2 to 20 carbon atoms include acetoxy, ethylcarbonyloxy, n-propylcarbonyloxy, isopropylcarbonyloxy, n-butylcarbonyloxy, and isopropylcarbonyloxy. Butylcarbonyloxy, tert-butylcarbonyloxy, n-pentylcarbonyloxy, isopentylcarbonyloxy, neopentylcarbonyloxy, n-hexylcarbonyloxy, n-heptylcarbonyloxy, n-octyl An alkanediylcarbonyloxy group formed by removing one hydrogen atom from an unsubstituted alkoxy group having 2 to 20 carbon atoms such as n-nonylcarbonyloxy group, n-nonylcarbonyloxy group, and n-decylcarbonyloxy group. The carbon number of the alkanediyl moiety of the alkanediylcarbonyloxy group is preferably 1-16, more preferably 1-12.

構成碳數2至20之烷醯氧基之1個以上氫原子亦可經鹵素原子(例如氟原子)、羥基、胺基或具有取代基之胺基取代。具有取代基之胺基與上述相同。作為1個以上氫原子經鹵素原子、羥基等取代之烷醯氧基,可列舉四氟乙基羰氧基、八氟丁基羰氧基等碳數2至20之鹵代醯氧基。One or more hydrogen atoms constituting the alkoxy group having 2 to 20 carbon atoms may be substituted with a halogen atom (for example, a fluorine atom), a hydroxyl group, an amino group, or an amino group having a substituent. The amino group having a substituent is the same as above. Examples of the alkoxy group in which one or more hydrogen atoms are substituted with a halogen atom, a hydroxyl group, etc. include halogenated acyloxy groups having 2 to 20 carbon atoms such as tetrafluoroethylcarbonyloxy and octafluorobutylcarbonyloxy.

式(1)中之R4 表示聚合性基或氫原子。作為R4 中之聚合性基,較佳為自由基聚合性基,例如可列舉(甲基)丙烯酸酯基、苯乙烯基等,其中,較佳為(甲基)丙烯酸酯基。 R 4 in the formula (1) represents a polymerizable group or a hydrogen atom. The polymerizable group in R 4 is preferably a radical polymerizable group, for example, a (meth)acrylate group, a styryl group, etc., and among them, a (meth)acrylate group is preferred.

式(1)所表示之化合物較佳為二色性色素。二色性色素係指具有分子之長軸方向上之吸光度與短軸方向上之吸光度不同之性質之色素。二色性色素較佳為具有吸收可見光之特性,更佳為於380 nm以上680 nm以下之範圍具有吸收極大波長(λMAX ),進而較佳為於420 nm以上520 nm以下之範圍具有吸收極大波長(λMAX )。The compound represented by formula (1) is preferably a dichroic dye. Dichroic pigments refer to pigments with properties that the absorbance in the direction of the long axis of the molecule is different from the absorbance in the direction of the short axis of the molecule. The dichroic pigment preferably has the characteristic of absorbing visible light, more preferably has a maximum absorption wavelength (λ MAX ) in the range from 380 nm to 680 nm, and more preferably has a maximum absorption in the range from 420 nm to 520 nm Wavelength (λ MAX ).

作為式(1)所表示之化合物之具體例,可列舉以下之式(2-2)至式(2-102)所表示之化合物,但本發明並不限定於該等。As specific examples of the compound represented by formula (1), the following compounds represented by formula (2-2) to formula (2-102) can be cited, but the present invention is not limited to these.

[化1]

Figure 02_image003
[化1]
Figure 02_image003

[化2]

Figure 02_image005
[化2]
Figure 02_image005

[化3]

Figure 02_image007
[化3]
Figure 02_image007

[化4]

Figure 02_image009
[化4]
Figure 02_image009

[化5]

Figure 02_image011
[化5]
Figure 02_image011

[化6]

Figure 02_image013
[化6]
Figure 02_image013

[化7]

Figure 02_image015
[化7]
Figure 02_image015

[化8]

Figure 02_image017
[化8]
Figure 02_image017

[化9]

Figure 02_image019
[化9]
Figure 02_image019

[化10]

Figure 02_image021
[化10]
Figure 02_image021

[化11]

Figure 02_image023
[化11]
Figure 02_image023

[化12]

Figure 02_image025
[化12]
Figure 02_image025

[化13]

Figure 02_image027
[化13]
Figure 02_image027

[化14]

Figure 02_image029
[化14]
Figure 02_image029

[化15]

Figure 02_image031
[化15]
Figure 02_image031

[化16]

Figure 02_image033
[化16]
Figure 02_image033

[化17]

Figure 02_image035
[化17]
Figure 02_image035

式(1)所表示之化合物較佳為式(2-2)至式(2-102)中選自由式(2-2)至式(2-7)、式(2-9)至式(2-30)、式(2-34)至式(2-42)、及式(2-47)至式(2-102)之任一者所表示之化合物所組成之群中之至少1種,其中,更佳為選自由式(2-3)至式(2-7)、式(2-9)至式(2-30)、式(2-34)至式(2-42)、及式(2-47)至式(2-102)之任一者所表示之化合物所組成之群中之至少1種,尤佳為選自由式(2-4)至式(2-7)、式(2-9)至式(2-30)、式(2-37)至式(2-41)、及式(2-47)至式(2-102)之任一者所表示之化合物所組成之群中之至少1種,進而較佳為選自由式(2-4)至式(2-7)、式(2-9)至式(2-30)、式(2-37)至式(2-41)、式(2-47)至式(2-65)、及式(2-75)至式(2-102)之任一者所表示之化合物所組成之群中之至少1種,尤其更佳為選自由式(2-4)至式(2-7)、式(2-9)至式(2-30)、式(2-47)至式(2-65)、及式(2-75)至式(2-102)之任一者所表示之化合物所組成之群中之至少1種。The compound represented by formula (1) is preferably selected from formula (2-2) to formula (2-102) from formula (2-2) to formula (2-7), formula (2-9) to formula ( 2-30), formula (2-34) to formula (2-42), and formula (2-47) to formula (2-102) represented by any one of the group consisting of at least one compound , Among them, more preferably selected from formula (2-3) to formula (2-7), formula (2-9) to formula (2-30), formula (2-34) to formula (2-42), And at least one of the group consisting of a compound represented by any one of formula (2-47) to formula (2-102), particularly preferably selected from formula (2-4) to formula (2-7) , Formula (2-9) to Formula (2-30), Formula (2-37) to Formula (2-41), and Formula (2-47) to Formula (2-102) At least one compound from the group consisting of compounds, more preferably selected from formula (2-4) to formula (2-7), formula (2-9) to formula (2-30), formula (2-37) ) To the group of compounds represented by any one of formula (2-41), formula (2-47) to formula (2-65), and formula (2-75) to formula (2-102) At least one of them, especially more preferably selected from formula (2-4) to formula (2-7), formula (2-9) to formula (2-30), formula (2-47) to formula (2- 65), and at least one of the group consisting of compounds represented by any one of formula (2-75) to formula (2-102).

(製造方法) 針對式(1)所表示之化合物(以下,亦稱為化合物(1))之製造方法進行說明。化合物(1)例如可利用式(1X)所表示之化合物[以下,亦稱為化合物(1X)]、及式(1Y)所表示之化合物[以下,亦稱為化合物(1Y)],藉由下述反應式所示之步驟而製造。(Production method) The method for producing the compound represented by formula (1) (hereinafter also referred to as compound (1)) will be described. Compound (1) can use, for example, a compound represented by formula (1X) [hereinafter, also referred to as compound (1X)] and a compound represented by formula (1Y) [hereinafter, also referred to as compound (1Y)], by It is produced by the steps shown in the following reaction formula.

[化18]

Figure 02_image037
[化18]
Figure 02_image037

於上述反應式中,Ar1 、Ar2 、Ar3 、R1 、R2 、R3 及R4 為與式(1)中之該等相同之含義。Re1 及Re2 為相互反應能夠形成R1 所表示之連結基或單鍵之基之組合。作為Re1 及Re2 之組合,例如可列舉以下。於R1 為單鍵之情形時,可列舉二羥基氧硼基或二烷氧基氧硼基與鹵素原子之組合等。於R1 為-C(=O)O-或-OC(=O)-之情形時,可列舉羧基與羥基之組合、羰基鹵化物基與羥基之組合、羰氧基烷基與羥基之組合等。於R1 為-C≡C-之情形時,例如可列舉鹵素原子與乙炔基(-C≡CH)之組合等。於R1 為-CH=CH-之情形時,例如可列舉鹵素原子與乙烯基(-CH=CH2 )之組合等。於R1 為-CH=N-或-N=CH-之情形時,例如可列舉甲醯基與胺基之組合等。In the above reaction formula, Ar 1 , Ar 2 , Ar 3 , R 1 , R 2 , R 3 and R 4 have the same meanings as those in formula (1). Re 1 and Re 2 are a combination of groups capable of forming a linking group or a single bond represented by R 1 by mutual reaction. Examples of the combination of Re 1 and Re 2 include the following. When R 1 is a single bond, a combination of a dihydroxyboronyl group or a dialkoxyboronyl group and a halogen atom, etc. may be mentioned. When R 1 is -C(=O)O- or -OC(=O)-, examples include the combination of a carboxyl group and a hydroxyl group, a combination of a carbonyl halide group and a hydroxyl group, and a combination of a carbonyloxyalkyl group and a hydroxyl group. Wait. When R 1 is -C≡C-, for example, a combination of a halogen atom and an ethynyl group (-C≡CH) and the like can be mentioned. When R 1 is -CH=CH-, for example, a combination of a halogen atom and a vinyl group (-CH=CH 2) and the like can be mentioned. When R 1 is -CH=N- or -N=CH-, for example, a combination of a formyl group and an amino group can be cited.

上述反應式中,說明了使用具有R4 -R3 -之化合物(1X)及具有R2 -之化合物(1Y)之製造方法,但亦可藉由如下方式而製造化合物(1):使利用適當之保護基對R4 -R3 -進行保護而得之化合物、及利用適當之保護基對R2 -進行保護而得之化合物相互反應,其後,進行適當之去保護反應。In the above reaction formula, the production method using the compound (1X) having R 4 -R 3 -and the compound (1Y) having R 2 -is described, but compound (1) can also be produced by the following method: A compound obtained by protecting R 4 -R 3 -with an appropriate protecting group and a compound obtained by protecting R 2 -with an appropriate protecting group are reacted with each other, and then an appropriate deprotection reaction is performed.

使化合物(1X)與化合物(1Y)反應時之反應條件可視使用之化合物(1X)及化合物(1Y)之種類適當選擇最佳之公知之條件。The reaction conditions when the compound (1X) is reacted with the compound (1Y) can be appropriately selected according to the types of the compound (1X) and the compound (1Y) to be used, and the best known conditions are appropriately selected.

例如,於R1 為單鍵、Re1 為二羥基氧硼基或二烷氧基氧硼基、Re2 為鹵素基之情形時,例如可參考Netherton, M. R.; Fu, G. C. Org. Lett. 2001, 3 (26), 4295-4298.等,使用鈴木偶合之反應條件。可藉由使用二乙二醇二甲醚與水之混合溶劑作為溶劑於乙酸鉀存在下加入PdCl2 dppf等Pd觸媒進行加熱而獲得化合物(1)。反應溫度可視化合物(1X)及化合物(1Y)之種類進行選擇,例如可列舉室溫至160℃之範圍,較佳為60℃至150℃之範圍。作為反應時間,例如可列舉15分鐘至48小時之範圍。再者,於Re1 為鹵素原子、Re2 為二羥基氧硼基或二烷氧基氧硼基之情形時,亦可相同地實施。For example, when R 1 is a single bond, Re 1 is a dihydroxyoxyboron group or a dialkoxyoxyboron group, and Re 2 is a halogen group, for example, refer to Netherton, MR; Fu, GC Org. Lett. 2001 , 3 (26), 4295-4298. etc., using the reaction conditions of Suzuki coupling. Compound (1) can be obtained by adding a Pd catalyst such as PdCl 2 dppf and heating in the presence of potassium acetate using a mixed solvent of diethylene glycol dimethyl ether and water as a solvent. The reaction temperature can be selected depending on the type of compound (1X) and compound (1Y), for example, a range of room temperature to 160°C, preferably a range of 60°C to 150°C. As a reaction time, the range of 15 minutes to 48 hours is mentioned, for example. In addition, when Re 1 is a halogen atom, and Re 2 is a dihydroxy oxyboron group or a dialkoxy oxyboron group, the same can be implemented.

再者,Re1 為二羥基氧硼基或二烷氧基氧硼基之化合物(1X)例如可藉由利用正丁基鋰等將Ar1 中之溴基鋰化之後使三烷氧基硼烷發揮作用以導入二羥基氧硼基或二烷氧基氧硼基而獲得。又,Re2 為二羥基氧硼基或二烷氧基氧硼基之化合物(1Y)例如可藉由利用正丁基鋰等將Ar2 中之溴基鋰化之後使三烷氧基硼烷化合物發揮作用以導入二羥基氧硼基或二烷氧基氧硼基而獲得。Furthermore, the compound (1X) in which Re 1 is a dihydroxyboronyl group or a dialkoxyboronyl group can be obtained by, for example, lithiuming the bromide group in Ar 1 with n-butyl lithium and then making trialkoxyboron The alkane functions by introducing a dihydroxyboronyl group or a dialkoxyboronyl group and is obtained. In addition, the compound (1Y) in which Re 2 is a dihydroxyboronyl group or a dialkoxyboronyl group can be obtained by, for example, lithiuming the bromide group in Ar 2 with n-butyllithium and then making a trialkoxyborane group. The compound functions by introducing a dihydroxyboronyl group or a dialkoxyboronyl group and is obtained.

化合物(1Y)中之偶氮結構例如可參考國際公開WO2016/136561號之段落[0220]至[0268]之製造例之記載等,藉由利用亞硝酸鈉等將具有一級胺基之芳香族胺化合物轉換為重氮鎓鹽,使其與芳香族化合物偶合而構建。The azo structure in the compound (1Y) can be referred to, for example, the description of the production examples in paragraphs [0220] to [0268] of International Publication WO2016/136561, etc. The aromatic amine having a primary amino group is obtained by using sodium nitrite or the like. The compound is converted into a diazonium salt, and it is constructed by coupling it with an aromatic compound.

例如作為R1 為-C(=O)O-、Re1 為羧基、Re2 為羥基之情形時之反應條件,可參考Jiang, L.; Lu, X.; Zhang, H.; Jiang, Y.; Ma, D. J. Org. Chem. 2009, 74 (3), 4542-4546.等使用脫水縮合反應。例如可列舉於溶劑中、於酯化縮合劑之存在下進行縮合之條件。作為溶劑,可列舉氯仿等可同時溶解化合物(1X)及化合物(1Y)之溶劑。作為酯化縮合劑,可列舉1-乙基-3-(3-二甲胺基丙基)碳二醯亞胺鹽酸鹽(EDC・HCl)、二異丙基碳二醯亞胺(IPC)等。此時,較佳為進而併用N,N-二甲胺基吡啶(DMAP)等鹼。反應溫度可視化合物(1X)及化合物(1Y)之種類進行選擇,例如可列舉-15℃至70℃之範圍,較佳為0℃至40℃之範圍。作為反應時間,例如可列舉15分鐘至48小時之範圍。再者,於R1 為-OC(=O)-、Re1 為羥基、Re2 為羧基之情形時,亦可相同地實施。For example , for the reaction conditions when R 1 is -C(=O)O-, Re 1 is a carboxyl group, and Re 2 is a hydroxyl group, refer to Jiang, L.; Lu, X.; Zhang, H.; Jiang, Y .; Ma, DJ Org. Chem. 2009, 74 (3), 4542-4546. etc. use dehydration condensation reaction. For example, the conditions for condensation in a solvent in the presence of an esterification condensing agent can be cited. As the solvent, a solvent capable of dissolving the compound (1X) and the compound (1Y) at the same time, such as chloroform, can be mentioned. As the esterification condensing agent, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC·HCl), diisopropylcarbodiimide (IPC )Wait. In this case, it is preferable to further use a base such as N,N-dimethylaminopyridine (DMAP) in combination. The reaction temperature can be selected depending on the type of compound (1X) and compound (1Y), for example, a range of -15°C to 70°C, preferably a range of 0°C to 40°C. As a reaction time, the range of 15 minutes to 48 hours is mentioned, for example. In addition, when R 1 is -OC(=O)-, Re 1 is a hydroxyl group, and Re 2 is a carboxyl group, the same can be implemented.

例如於R1 為-C≡C-、Re1 為乙炔基(-C≡CH)、Re2 為鹵素原子之情形時,可應用使用Pd、Cu觸媒之薗頭偶合來合成化合物(1)。再者,於Re1 為鹵素原子、Re2 為乙炔基(-C≡CH)之情形時,亦可相同地實施。For example, when R 1 is -C≡C-, Re 1 is an ethynyl group (-C≡CH), and Re 2 is a halogen atom, the compound (1) can be synthesized by using Pd and Cu as a catalyst. . In addition, when Re 1 is a halogen atom and Re 2 is an ethynyl group (-C≡CH), the same can be implemented.

例如於R1 為-C=C-、Re1 為乙烯基(-CH=CH2 )、Re2 為鹵素基之情形時,可應用使用Pd觸媒、磷配位基之Heck反應來合成化合物(1)。再者,於Re1 為鹵素原子、Re2 為乙烯基(-CH=CH2 )之情形時,亦可相同地實施。For example, when R 1 is -C=C-, Re 1 is vinyl (-CH=CH 2 ), and Re 2 is a halogen group, the Heck reaction using Pd catalyst and phosphorus ligand can be used to synthesize the compound (1). In addition, when Re 1 is a halogen atom and Re 2 is a vinyl group (-CH=CH 2 ), the same can be implemented.

例如於R1 為-CH=N-、Re1 為甲醯基、Re2 為胺基之情形時,可藉由應用一般之脫水縮合反應來合成化合物(1)。再者,於R1 為-N=CH-、Re1 為胺基、Re2 為甲醯基之情形時,亦可相同地實施。For example, when R 1 is -CH=N-, Re 1 is a formyl group, and Re 2 is an amine group, compound (1) can be synthesized by applying a general dehydration condensation reaction. In addition, when R 1 is -N=CH-, Re 1 is an amino group, and Re 2 is a methyl group, the same can be implemented.

於所獲得之化合物(1)中之R3 為碳數2至20之烷二基氧基羰基之情形時,可藉由一般之酯交換反應使R3 變為其他碳數2至20之烷二基氧基羰基。於酯交換反應時,例如以Chen, C.-T.; Kuo, J.-H.; Ku, C.-H.; Weng, S.-S.; Liu, C.-Y. J. Org. Chem. 2005, 70 (4), 1328-1339.等為參考,可應用使用TiO(acac)2 (名稱:雙(2,4-戊二酮基)鈦(IV)氧化物)作為路易斯酸觸媒於溶劑中與醇化合物一起加熱之方法。作為溶劑,可使用二甲苯、甲苯等烴系芳香族化合物。再者,其他碳數2至20之烷二基氧基羰基包含烷二基部分不同者,可碳數不同,又,亦可取代基不同。When the compound R (1) in the case of 3 carbon atoms alkoxy group having 2 to 20 bis carbonyl group to the obtained sum, the transesterification may be of generally by reacting other alkoxy R 3 changes of 2 to 20 carbon atoms of Diyloxycarbonyl. In the transesterification reaction, for example, Chen, C.-T.; Kuo, J.-H.; Ku, C.-H.; Weng, S.-S.; Liu, C.-YJ Org. Chem. 2005, 70 (4), 1328-1339. For reference, TiO(acac) 2 (name: bis(2,4-pentanedionyl) titanium(IV) oxide) can be used as a Lewis acid catalyst A method of heating with alcohol compounds in a solvent. As the solvent, a hydrocarbon-based aromatic compound such as xylene and toluene can be used. In addition, other alkanediyloxycarbonyl groups having 2 to 20 carbon atoms include those with different alkanediyl moieties, which may have different carbon numbers, and may also have different substituents.

化合物(1)之製造方法之反應時間亦可對反應過程中之反應混合物進行適當採樣,並藉由液相層析儀、氣相層析儀等公知之分析機構確認化合物(1X)及化合物(1Y)之消失程度、化合物(1)之生成程度等而決定。The reaction time of the production method of compound (1) can also appropriately sample the reaction mixture in the reaction process, and confirm the compound (1X) and compound ( It is determined by the degree of disappearance of 1Y) and the degree of production of compound (1).

藉由再結晶、再沈澱、萃取及各種層析法等公知之方法或藉由將該等操作適當組合,可自反應後之反應混合物萃取出化合物(1)。The compound (1) can be extracted from the reaction mixture after the reaction by well-known methods such as recrystallization, reprecipitation, extraction, and various chromatographic methods, or by appropriately combining these operations.

<組合物> 針對包含式(1)所表示之化合物之組合物進行說明。本實施方式之組合物係包含式(1)所表示之化合物例如作為色素化合物且視需要包含液體介質等其他成分而構成。關於組合物中之式(1)所表示之化合物之含量,相對於組合物之固形物成分100質量份,較佳為50質量份以下,更佳為0.1質量份以上10質量份以下之範圍,進而較佳為0.1質量份以上5質量份以下之範圍。若為上述範圍內,則式(1)所表示之化合物能夠充分地分散。藉此,能夠有效率地獲得以式(1)所表示之化合物作為形成材料之缺陷產生得到充分地抑制之膜。再者,於本說明書中,固形物成分係指自組合物除去溶劑等揮發性成分之成分之合計量。<Composition> The composition containing the compound represented by formula (1) will be described. The composition of this embodiment is comprised including the compound represented by Formula (1), for example as a pigment compound, and other components, such as a liquid medium, if necessary. Regarding the content of the compound represented by formula (1) in the composition, relative to 100 parts by mass of the solid content of the composition, it is preferably 50 parts by mass or less, and more preferably in the range of 0.1 parts by mass to 10 parts by mass, More preferably, it is the range of 0.1 mass part or more and 5 mass parts or less. If it is in the above range, the compound represented by formula (1) can be sufficiently dispersed. Thereby, it is possible to efficiently obtain a film in which the occurrence of defects in the compound represented by the formula (1) as a forming material is sufficiently suppressed. In addition, in this specification, the solid content refers to the total amount of the components from the composition in which volatile components such as solvents are removed.

[其他成分] (其他色素化合物) 組合物亦可進而包含除式(1)所表示之化合物以外之其他色素化合物、例如二色性色素之至少1種。作為其他色素化合物,例如可列舉單偶氮色素、雙偶氮色素、三偶氮色素、四偶氮色素、茋偶氮色素等偶氮色素,較佳為選自由該等所組成之群中之至少1種。組合物可單獨包含1種其他色素化合物,亦可組合包含2種以上。例如於用作塗佈型偏光板材料之情形時,組合物包含之其他色素化合物較佳為於與式(1)所表示之化合物不同之波長範圍具有極大吸收波長。於用作塗佈型偏光板材料之情形時,組合物較佳為包含式(1)所表示之化合物且組合包含3種以上二色性色素,更佳為組合包含3種類以上偶氮色素。藉由組合物組合包含極大吸收波長不同之3種以上色素化合物,例如利用由組合物所形成之膜能夠於可見光全域獲得吸收。[Other ingredients] (Other pigment compounds) The composition may further include at least one other coloring compound other than the compound represented by formula (1), for example, dichroic coloring. As other pigment compounds, for example, azo pigments such as monoazo pigments, bisazo pigments, trisazo pigments, tetrazo pigments, stilbene azo pigments, etc., are preferably selected from the group consisting of these At least one. The composition may contain one kind of other coloring compound alone, or two or more kinds in combination. For example, when used as a coating-type polarizing plate material, the other pigment compound contained in the composition preferably has a maximum absorption wavelength in a wavelength range different from the compound represented by formula (1). When used as a coating type polarizing plate material, the composition preferably contains the compound represented by formula (1) and contains three or more dichroic dyes in combination, and more preferably contains three or more azo dyes in combination. When the composition includes three or more pigment compounds with different absorption wavelengths, for example, the film formed by the composition can absorb the entire visible light.

於組合物包含其他色素化合物之情形時,其含量相對於組合物之固形物成分100質量份較佳為50質量份以下,更佳為0.1質量份以上10質量份以下之範圍,進而較佳為0.1質量份以上5質量份以下之範圍。若為上述範圍內,則其他色素化合物能夠充分地分散。When the composition contains other pigment compounds, the content is preferably 50 parts by mass or less relative to 100 parts by mass of the solid content of the composition, more preferably 0.1 parts by mass or more and 10 parts by mass or less, and more preferably The range is from 0.1 part by mass to 5 parts by mass. If it is in the above-mentioned range, other dye compounds can be sufficiently dispersed.

(聚合性液晶化合物) 組合物亦可除式(1)所表示之化合物以外進而包含聚合性液晶化合物之至少1種。聚合性液晶化合物係於分子內具有聚合性基、藉由配向能夠呈液晶相之化合物。聚合性液晶化合物較佳為藉由單獨配向能夠呈液晶相之化合物。組合物可包含1種單獨之聚合性液晶化合物,亦可包含2種以上之聚合性液晶化合物。(Polymerizable liquid crystal compound) The composition may contain at least one type of polymerizable liquid crystal compound in addition to the compound represented by formula (1). The polymerizable liquid crystal compound is a compound that has a polymerizable group in the molecule and can assume a liquid crystal phase by alignment. The polymerizable liquid crystal compound is preferably a compound capable of exhibiting a liquid crystal phase by individual alignment. The composition may include one single polymerizable liquid crystal compound, or two or more polymerizable liquid crystal compounds.

聚合性基意指參與聚合反應之基,較佳為光聚合性基。此處,聚合性基係指藉由自下文所述之聚合起始劑所產生之活性自由基、酸等能夠參與聚合反應之基。作為聚合性基,可列舉:乙烯基、乙烯基氧基、1-氯乙烯基、異丙烯基、4-乙烯基苯基、丙烯醯氧基、甲基丙烯醯氧基、環氧乙烷基、及氧雜環丁基。其中,聚合性基較佳為選自由丙烯醯氧基、甲基丙烯醯氧基、乙烯基氧基、環氧乙烷基、及氧雜環丁基所組成之群中之至少1種,更佳為丙烯醯氧基。The polymerizable group means a group that participates in a polymerization reaction, and a photopolymerizable group is preferred. Here, the polymerizable group refers to a group capable of participating in the polymerization reaction by living radicals, acids, etc. generated from the polymerization initiator described below. Examples of polymerizable groups include vinyl groups, vinyloxy groups, 1-chlorovinyl groups, isopropenyl groups, 4-vinylphenyl groups, acryloxy groups, methacryloxy groups, and oxirane groups. , And oxetanyl. Among them, the polymerizable group is preferably at least one selected from the group consisting of acryloxy group, methacryloxy group, vinyloxy group, oxirane group, and oxetanyl group, and more Preferably it is propylene oxy group.

聚合性液晶化合物可為可構成熱致性液晶型聚合物者,亦可為可構成溶致性液晶型聚合物者。The polymerizable liquid crystal compound may be one that can constitute a thermotropic liquid crystal type polymer, or one that can constitute a lyotropic liquid crystal type polymer.

聚合性液晶化合物可為呈向列型液晶相之化合物,亦可為呈層列型液晶相之化合物,亦可為呈向列型液晶相及層列型液晶相之兩者之化合物。較佳為呈層列型液晶相之化合物,更佳為呈高次層列型液晶相之化合物。包含呈層列型液晶相之聚合性液晶化合物之組合物能夠提供偏光性能更優異之偏光膜。The polymerizable liquid crystal compound may be a compound in a nematic liquid crystal phase, a compound in a smectic liquid crystal phase, or a compound in both a nematic liquid crystal phase and a smectic liquid crystal phase. It is preferably a compound exhibiting a smectic liquid crystal phase, and more preferably a compound exhibiting a higher order smectic liquid crystal phase. The composition containing the polymerizable liquid crystal compound in the smectic liquid crystal phase can provide a polarizing film with more excellent polarization performance.

即便為式(1)所表示之化合物分散於由呈層列型液晶相之聚合性液晶化合物所形成之緻密分子鏈間中之狀態,亦能夠表現出較高之二色性。因此,包含式(1)所表示之化合物、及聚合性液晶化合物、特別是呈層列型液晶相之聚合性液晶化合物之組合物能夠提供二色比較高之偏光膜。Even in a state where the compound represented by formula (1) is dispersed in dense molecular chains formed by a polymerizable liquid crystal compound in a smectic liquid crystal phase, it can exhibit high dichroism. Therefore, a composition containing the compound represented by the formula (1) and a polymerizable liquid crystal compound, particularly a polymerizable liquid crystal compound in a smectic liquid crystal phase, can provide a polarizing film with a high two-color ratio.

作為高次層列型液晶相,可列舉:層列B相、層列D相、層列E相、層列F相、層列G相、層列H相、層列I相、層列J相、層列K相、及層列L相。其中,較佳為層列B相、層列F相、及層列I相,更佳為層列B相。若聚合性液晶化合物所呈現出之層列型液晶相為該等高次層列相,則可獲得配向秩序度更高之偏光膜。由包含呈現出配向秩序度較高之高次層列型液晶相之聚合性液晶化合物之組合物所獲得之偏光膜於X射線繞射測定中出現源自六角相或晶體相等高次結構之布勒格波峰。布勒格波峰係源自分子配向之面週期結構之波峰。由組合物所獲得之偏光膜所具有之週期間隔(秩序週期)較佳為0.30 nm以上0.60 nm以下。Examples of the higher order smectic liquid crystal phase include: smectic B phase, smectic D phase, smectic E phase, smectic F phase, smectic G phase, smectic H phase, smectic I phase, smectic J Phase, smectic K phase, and smectic L phase. Among them, the smectic B phase, the smectic F phase, and the smectic I phase are preferable, and the smectic B phase is more preferable. If the smectic liquid crystal phase exhibited by the polymerizable liquid crystal compound is these higher order smectic phases, a polarizing film with a higher degree of alignment order can be obtained. A polarizing film obtained from a composition containing a polymerizable liquid crystal compound exhibiting a high-order smectic liquid crystal phase with a high degree of alignment appears to be derived from a hexagonal phase or a crystal-like high-order structure in the X-ray diffraction measurement. Rouge crest. The Buhrer wave peak is derived from the wave peak of the surface periodic structure of molecular alignment. The period interval (order period) of the polarizing film obtained from the composition is preferably 0.30 nm or more and 0.60 nm or less.

聚合性液晶化合物呈現出之液晶相之種類例如可利用以下所示之方法進行確認。即,準備適當之基材,於該基材上塗佈包含聚合性液晶化合物及溶劑之溶液以形成塗佈膜,其後進行加熱處理或減壓處理,藉此將該塗佈膜中所含有之溶劑去除。繼而,將形成於基材上之塗佈膜加熱至各向同性相溫度後,緩慢地進行冷卻,針對藉此呈現出之液晶相,藉由利用偏光顯微鏡之質構觀察、X射線繞射測定或示差掃描熱量測定來進行檢查。於該檢查中,例如可確認如下情況:藉由冷卻至第一溫度而呈向列型液晶相,進而藉由緩慢地冷卻至第二溫度而呈層列型液晶相。The type of liquid crystal phase exhibited by the polymerizable liquid crystal compound can be confirmed by the method shown below, for example. That is, a suitable substrate is prepared, a solution containing a polymerizable liquid crystal compound and a solvent is applied to the substrate to form a coating film, and then heat treatment or reduced pressure treatment is performed to thereby the coating film contains The solvent is removed. Then, the coating film formed on the substrate is heated to the temperature of the isotropic phase, and then slowly cooled, and the liquid crystal phase presented thereby is measured by texture observation using a polarizing microscope and X-ray diffraction measurement Or differential scanning calorimetry to check. In this inspection, for example, it can be confirmed that the liquid crystal phase becomes a nematic liquid crystal phase by being cooled to the first temperature, and then a smectic liquid crystal phase is formed by cooling slowly to the second temperature.

聚合性液晶化合物較佳為式(4)所表示之化合物(以下,有時記為「化合物(4)」)。The polymerizable liquid crystal compound is preferably a compound represented by formula (4) (hereinafter, sometimes referred to as "compound (4)").

U1 -V1 -W1 -X1 -Y1 -X2 -Y2 -X3 -W2 -V2 -U2 (4) 式中,X1 、X2 及X3 分別獨立,表示可具有取代基之1,4-伸苯基、或可具有取代基之環己烷-1,4-二基;其中,X1 、X2 及X3 中之至少1者為可具有取代基之1,4-伸苯基;又,構成環己烷-1,4-二基之-CH2 -之至少1者亦可被取代為-O-、-S-或-NR-;此處,R表示碳數1至6之烷基或苯基; Y1 及Y2 分別獨立,表示單鍵、-CH2 CH2 -、-CH2 O-、-(C=O)O-、-O(C=O)O-、-N=N-、-CRa =CRb -、-C≡C-、或-CRa =N-;Ra 及Rb 分別獨立,表示氫原子或碳數1至4之烷基; U1 表示氫原子或聚合性基; U2 表示聚合性基; W1 及W2 分別獨立,表示單鍵、-O-、-S-、-(C=O)O-、或-O(C=O)O-; V1 及V2 分別獨立,表示可具有取代基之碳數1至20之烷二基,構成該烷二基之-CH2 -亦可被取代為-O-、-S-或-NH-)U 1 -V 1 -W 1 -X 1 -Y 1 -X 2 -Y 2 -X 3 -W 2 -V 2 -U 2 (4) In the formula, X 1 , X 2 and X 3 are independent respectively, which means The 1,4-phenylene group which may have a substituent, or the cyclohexane-1,4-diyl group which may have a substituent; wherein at least one of X 1 , X 2 and X 3 is a group which may have a substituent In addition, at least 1 of -CH 2 -constituting the cyclohexane-1,4-diyl group may be substituted with -O-, -S- or -NR-; here , R represents an alkyl group or a phenyl group with carbon numbers 1 to 6; Y 1 and Y 2 are independent of each other and represent a single bond, -CH 2 CH 2 -, -CH 2 O-, -(C=O)O-,- O (C = O) O - , - N = N -, - CR a = CR b -, - C≡C-, or -CR a = N-; R a and R b each independently represents a hydrogen atom or a C An alkyl group having a number of 1 to 4; U 1 represents a hydrogen atom or a polymerizable group; U 2 represents a polymerizable group; W 1 and W 2 are independent of each other and represent a single bond, -O-, -S-, -(C=O )O-, or -O(C=O)O-; V 1 and V 2 are independent of each other and represent an alkanediyl group with a carbon number of 1 to 20 that may have a substituent, and -CH 2 -constituting the alkanediyl group is also Can be substituted with -O-, -S- or -NH-)

可具有取代基之1,4-伸苯基較佳為不具有取代基之1,4-伸苯基。可具有取代基之環己烷-1,4-二基較佳為可具有取代基之反式-環己烷-1,4-二基。可具有取代基之反式-環己烷-1,4-二基較佳為不具有取代基之反式-環己烷-1,4-二基。The 1,4-phenylene group which may have a substituent is preferably the 1,4-phenylene group which has no substituent. The cyclohexane-1,4-diyl group which may have a substituent is preferably a trans-cyclohexane-1,4-diyl group which may have a substituent. The trans-cyclohexane-1,4-diyl group which may have a substituent is preferably the trans-cyclohexane-1,4-diyl group which has no substituent.

作為可具有取代基之1,4-伸苯基、或可具有取代基之環己烷-1,4-二基任意具有之取代基可列舉甲基、乙基、正丁基等碳數1至4之烷基、氰基、及鹵素原子等。As the 1,4-phenylene group which may have a substituent, or the cyclohexane-1,4-diyl group which may have a substituent, the optional substituents include methyl, ethyl, n-butyl and other carbon number 1 Up to 4 alkyl groups, cyano groups, and halogen atoms, etc.

Y1 較佳為單鍵、-CH2 CH2 -、或-(C=O)O-,Y2 較佳為-CH2 H2 -或-CH2 O-。Y 1 is preferably a single bond, -CH 2 CH 2 -, or -(C=O)O-, and Y 2 is preferably -CH 2 H 2 -or -CH 2 O-.

U1 為氫原子或聚合性基,較佳為聚合性基。U2 為聚合性基。U1 及U2 較佳為同時為聚合性基,更佳為同時為光聚合性基。具有光聚合性基之聚合性液晶化合物於能夠於更低溫條件下聚合之方面有利。U 1 is a hydrogen atom or a polymerizable group, preferably a polymerizable group. U 2 is a polymerizable group. U 1 and U 2 are preferably both a polymerizable group, and more preferably are both a photopolymerizable group. The polymerizable liquid crystal compound having a photopolymerizable group is advantageous in that it can be polymerized under lower temperature conditions.

U1 及U2 所表示之聚合性基亦可互不相同,但較佳為相同。作為聚合性基,可列舉:乙烯基、乙烯基氧基、1-氯乙烯基、異丙烯基、4-乙烯基苯基、丙烯醯氧基、甲基丙烯醯氧基、環氧乙烷基、及氧雜環丁基。其中,U1 及U2 所表示之聚合性基較佳為選自由乙烯基氧基、丙烯醯氧基、甲基丙烯醯氧基、環氧乙烷基、及氧雜環丁基所組成之群中之至少1種,更佳為丙烯醯氧基。The polymerizable groups represented by U 1 and U 2 may be different from each other, but are preferably the same. Examples of polymerizable groups include vinyl groups, vinyloxy groups, 1-chlorovinyl groups, isopropenyl groups, 4-vinylphenyl groups, acryloxy groups, methacryloxy groups, and oxirane groups. , And oxetanyl. Among them, the polymerizable groups represented by U 1 and U 2 are preferably selected from vinyloxy, acryloxy, methacryloxy, oxiranyl, and oxetanyl groups. At least one of the group, more preferably acryloxy group.

作為V1 及V2 所表示之烷二基,可列舉:亞甲基、伸乙基、丙烷-1,3-二基、丁烷-1,3-二基、丁烷-1,4-二基、戊烷-1,5-二基、己烷-1,6-二基、庚烷-1,7-二基、辛烷-1,8-二基、癸烷-1,10-二基、十四烷-1,1-二基、及二十烷-1,20-二基。V1 及V2 較佳為碳數2至12之烷二基,更佳為碳數6至12之烷二基。Examples of the alkanediyl group represented by V 1 and V 2 include methylene, ethylene, propane-1,3-diyl, butane-1,3-diyl, butane-1,4- Diyl, pentane-1,5-diyl, hexane-1,6-diyl, heptane-1,7-diyl, octane-1,8-diyl, decane-1,10- Diyl, tetradecane-1,1-diyl, and eicosan-1,20-diyl. V 1 and V 2 are preferably alkanediyl groups having 2 to 12 carbon atoms, and more preferably alkanediyl groups having 6 to 12 carbon atoms.

作為可具有取代基之碳數1至20之烷二基任意具有之取代基可列舉氰基及鹵素原子。該烷二基較佳為不具有取代基之烷二基,更佳為不具有取代基且直鏈狀之烷二基。Examples of the substituent optionally possessed by the alkanediyl group having 1 to 20 carbon atoms which may have a substituent include a cyano group and a halogen atom. The alkanediyl group is preferably an alkanediyl group having no substituents, and more preferably a straight-chain alkanediyl group having no substituents.

W1 及W2 較佳為分別獨立,為單鍵或-O-。W 1 and W 2 are preferably independent of each other and are a single bond or -O-.

作為化合物(4)之具體例,可列舉下述式(4-1)至式(4-43)所表示之化合物。於化合物(4)具有環己烷-1,4-二基之情形時,其環己烷-1,4-二基較佳為反式型。Specific examples of the compound (4) include compounds represented by the following formula (4-1) to (4-43). When the compound (4) has a cyclohexane-1,4-diyl group, the cyclohexane-1,4-diyl group is preferably a trans type.

[化19]

Figure 02_image039
[化19]
Figure 02_image039

[化20]

Figure 02_image041
[化20]
Figure 02_image041

[化21]

Figure 02_image043
[化21]
Figure 02_image043

[化22]

Figure 02_image045
[化22]
Figure 02_image045

[化23]

Figure 02_image047
[化23]
Figure 02_image047

[化24]

Figure 02_image049
[化24]
Figure 02_image049

[化25]

Figure 02_image051
[化25]
Figure 02_image051

[化26]

Figure 02_image053
[化26]
Figure 02_image053

[化27]

Figure 02_image055
[化27]
Figure 02_image055

其中,化合物(4)較佳為選自由式(4-5)、式(4-6)、式(4-7)、式(4-8)、式(4-9)、式(4-10)、式(4-11)、式(4-12)、式(4-13)、式(4-14)、式(4-15)、式(4-22)、式(4-24)、式(4-25)、式(4-26)、式(4-27)、式(4-28)、及式(4-29)之任一者所表示之化合物所組成之群的至少1種所表示之化合物。Among them, compound (4) is preferably selected from formula (4-5), formula (4-6), formula (4-7), formula (4-8), formula (4-9), formula (4- 10), formula (4-11), formula (4-12), formula (4-13), formula (4-14), formula (4-15), formula (4-22), formula (4-24) ), formula (4-25), formula (4-26), formula (4-27), formula (4-28), and formula (4-29) At least one of the compounds represented.

化合物(4)例如可藉由Lub etal. Recl. Trav. Chim. Pays-Bas, 115, 321-328(1996)、日本專利第4719156號公報等公知文獻中記載之方法來製造。Compound (4) can be produced, for example, by a method described in publicly known documents such as Lub et al. Recl. Trav. Chim. Pays-Bas, 115, 321-328 (1996), Japanese Patent No. 4719156.

組合物亦可包含2種以上之聚合性液晶化合物。於將2種以上之聚合性液晶化合物進行組合之情形時,較佳為其中之至少1種為化合物(4),更佳為其中之2種以上為化合物(4)。藉由將2種以上之聚合性液晶化合物進行組合,存在即便為液晶-結晶相轉移溫度以下之溫度亦能夠暫時保持液晶相之情況。關於組合物中所包含之化合物(4)之含量,相對於組合物中之所有聚合性液晶化合物之總質量,合計較佳為40質量%以上,更佳為60質量%以上,亦可所有聚合性液晶化合物為化合物(4)。若化合物(4)之含量為上述範圍內,則聚合性液晶化合物容易以較高之配向秩序度排列,且式(1)所表示之化合物沿著其進行配向,藉此能夠獲得具有優異之偏光性能之偏光膜。The composition may also contain two or more polymerizable liquid crystal compounds. When combining two or more types of polymerizable liquid crystal compounds, it is preferable that at least one of them is the compound (4), and it is more preferable that two or more of them are the compound (4). By combining two or more types of polymerizable liquid crystal compounds, there are cases where the liquid crystal phase can be temporarily maintained even at a temperature below the liquid crystal-crystal phase transition temperature. Regarding the content of the compound (4) contained in the composition, relative to the total mass of all polymerizable liquid crystal compounds in the composition, the total is preferably 40% by mass or more, more preferably 60% by mass or more, and all can be polymerized. The sexual liquid crystal compound is compound (4). If the content of the compound (4) is within the above range, the polymerizable liquid crystal compound is easily aligned with a higher degree of alignment order, and the compound represented by the formula (1) is aligned along it, thereby obtaining excellent polarized light Performance polarizing film.

關於組合物中之聚合性液晶化合物之含有比率,就提高聚合性液晶化合物之配向性之觀點而言,相對於組合物之固形物成分100質量份,較佳為70質量份以上99.5質量份以下,更佳為80質量份以上99質量份以下,進而較佳為80質量份以上94質量份以下。Regarding the content ratio of the polymerizable liquid crystal compound in the composition, from the viewpoint of improving the orientation of the polymerizable liquid crystal compound, relative to 100 parts by mass of the solid content of the composition, it is preferably 70 parts by mass or more and 99.5 parts by mass or less , More preferably 80 parts by mass or more and 99 parts by mass or less, and still more preferably 80 parts by mass or more and 94 parts by mass or less.

(高分子化合物) 組合物亦可除式(1)所表示之化合物以外進而包含高分子化合物。藉由組合物包含高分子化合物,能夠構成式(1)所表示之化合物分散於高分子化合物而成之組合物。(Polymer compound) The composition may further include a polymer compound in addition to the compound represented by formula (1). When the composition contains a polymer compound, it is possible to constitute a composition in which the compound represented by formula (1) is dispersed in the polymer compound.

作為組合物可包含之高分子化合物,只要可使式(1)所表示之化合物分散,則並無特別限制,可列舉:聚乙烯、聚丙烯等聚烯烴;降𦯉烯聚合物等環狀烯烴樹脂;聚伸烷基醚、聚乙烯醇;聚甲基丙烯酸酯;聚丙烯酸酯等,該等高分子化合物具有液晶性之有機基。其中,就容易使式(1)所表示之化合物均勻地分散之方面而言,較佳為聚甲基丙烯酸酯、聚丙烯酸酯。組合物包含之高分子化合物可為1種,亦可為2種以上。The polymer compound that can be included in the composition is not particularly limited as long as the compound represented by formula (1) can be dispersed. Examples include polyolefins such as polyethylene and polypropylene; and cyclic olefins such as norene polymers. Resin; polyalkylene ether, polyvinyl alcohol; polymethacrylate; polyacrylate, etc. These high molecular compounds have liquid crystal organic groups. Among them, polymethacrylate and polyacrylate are preferred from the viewpoint that it is easy to uniformly disperse the compound represented by formula (1). The polymer compound contained in the composition may be one type or two or more types.

作為組合物可包含之高分子化合物,亦可為液晶性高分子化合物,例如可列舉上述聚合性液晶化合物之聚合物。作為上述聚合性液晶化合物之聚合物之構成單體之上述聚合性液晶化合物可為1種,亦可為2種以上。組合物亦可包含上述聚合性液晶化合物及其聚合物。The polymer compound that can be contained in the composition may also be a liquid crystal polymer compound, and examples thereof include polymers of the above-mentioned polymerizable liquid crystal compound. The polymerizable liquid crystal compound as a constituent monomer of the polymer of the polymerizable liquid crystal compound may be one type or two or more types. The composition may also include the above-mentioned polymerizable liquid crystal compound and a polymer thereof.

高分子化合物之聚苯乙烯換算之重量平均分子量例如為1萬以上20萬以下,較佳為2萬以上15萬以下。The weight average molecular weight of the polymer compound in terms of polystyrene is, for example, 10,000 or more and 200,000 or less, preferably 20,000 or more and 150,000 or less.

於組合物包含高分子化合物之情形時,其含量可視目的等適當選擇。高分子化合物之含量相對於組合物之固形物成分100質量份較佳為70質量份以上99.5質量份以下,更佳為80質量份以上99質量份以下之範圍,進而較佳為80質量份以上94質量份以下之範圍。When the composition contains a polymer compound, its content can be appropriately selected depending on the purpose and the like. The content of the polymer compound relative to 100 parts by mass of the solid content of the composition is preferably 70 parts by mass or more and 99.5 parts by mass or less, more preferably in the range of 80 parts by mass or more and 99 parts by mass or less, and more preferably 80 parts by mass or more The range of 94 parts by mass or less.

於組合物包含化合物(1)及聚合性液晶化合物之情形時,組合物中之化合物(1)之含量相對於聚合性液晶化合物100質量份通常為0.1質量份以上50質量份以下,較佳為0.1質量份以上20質量份以下,更佳為0.1質量份以上10質量份以下,進而較佳為0.1質量份以上5質量份以下。若化合物(1)之含量相對於聚合性液晶化合物100質量份為50質量份以下,則聚合性液晶化合物與化合物(1)之配向之混亂較少,存在能夠獲得具有較高之配向秩序度之膜之傾向。When the composition contains the compound (1) and the polymerizable liquid crystal compound, the content of the compound (1) in the composition relative to 100 parts by mass of the polymerizable liquid crystal compound is usually 0.1 parts by mass or more and 50 parts by mass or less, preferably 0.1 parts by mass or more and 20 parts by mass or less, more preferably 0.1 parts by mass or more and 10 parts by mass or less, and still more preferably 0.1 parts by mass or more and 5 parts by mass or less. If the content of the compound (1) is 50 parts by mass or less with respect to 100 parts by mass of the polymerizable liquid crystal compound, there will be less confusion in the alignment of the polymerizable liquid crystal compound and the compound (1), and a higher degree of alignment order can be obtained. The tendency of the membrane.

於組合物包含化合物(1)及高分子化合物之情形時,組合物中之化合物(1)之含量相對於高分子化合物100質量份通常為0.1質量份以上50質量份以下,較佳為0.1質量份以上20質量份以下,更佳為0.1質量份以上10質量份以下,進而較佳為0.1質量份以上5質量份以下。於上述高分子化合物為液晶性高分子化合物之情形時,若化合物(1)之含量相對於液晶性高分子化合物100質量份為50質量份以下,則液晶性高分子化合物與化合物(1)之配向之混亂較少,存在能夠獲得具有較高之配向秩序度之膜之傾向。When the composition contains the compound (1) and the polymer compound, the content of the compound (1) in the composition relative to 100 parts by mass of the polymer compound is usually 0.1 parts by mass or more and 50 parts by mass or less, preferably 0.1 parts by mass Part or more and 20 parts by mass or less, more preferably 0.1 part by mass or more and 10 parts by mass or less, and still more preferably 0.1 part by mass or more and 5 parts by mass or less. When the above-mentioned polymer compound is a liquid crystal polymer compound, if the content of the compound (1) is 50 parts by mass or less relative to 100 parts by mass of the liquid crystal polymer compound, the liquid crystal polymer compound and the compound (1) There is less confusion in the alignment, and there is a tendency to obtain a film with a higher degree of alignment order.

組合物較佳為進而包含溶劑等液體介質及聚合起始劑,亦可視需要進而包含光敏劑、聚合抑制劑、調平劑等。The composition preferably further includes a liquid medium such as a solvent and a polymerization initiator, and may further include a photosensitizer, a polymerization inhibitor, a leveling agent, and the like as needed.

(溶劑) 溶劑較佳為能夠完全溶解化合物(1)、聚合性液晶化合物及高分子化合物之溶劑。又,較佳為於聚合性液晶化合物之聚合反應中為惰性之溶劑。(Solvent) The solvent is preferably a solvent that can completely dissolve the compound (1), the polymerizable liquid crystal compound, and the polymer compound. In addition, it is preferably a solvent that is inert in the polymerization reaction of the polymerizable liquid crystal compound.

作為溶劑,可列舉:甲醇、乙醇、乙二醇、異丙醇、丙二醇、乙二醇甲醚、乙二醇丁醚、丙二醇單甲醚等醇溶劑;乙酸乙酯、乙酸丁酯、乙二醇甲醚乙酸酯、γ-丁內酯、丙二醇甲醚乙酸酯、乳酸乙酯等酯溶劑;丙酮、甲基乙基酮、環戊酮、環己酮、2-庚酮、甲基異丁基酮等酮溶劑;戊烷、己烷、庚烷等脂肪族烴溶劑;甲苯、二甲苯等芳香族烴溶劑;乙腈等腈溶劑;四氫呋喃、二甲氧基乙烷等醚溶劑;及氯仿、氯苯等含氯溶劑。該等溶劑可僅使用1種,亦可將2種以上組合使用。Examples of solvents include alcohol solvents such as methanol, ethanol, ethylene glycol, isopropanol, propylene glycol, ethylene glycol methyl ether, ethylene glycol butyl ether, and propylene glycol monomethyl ether; ethyl acetate, butyl acetate, and ethylene diethyl ether. Alcohol methyl ether acetate, γ-butyrolactone, propylene glycol methyl ether acetate, ethyl lactate and other ester solvents; acetone, methyl ethyl ketone, cyclopentanone, cyclohexanone, 2-heptanone, methyl Ketone solvents such as isobutyl ketone; aliphatic hydrocarbon solvents such as pentane, hexane, and heptane; aromatic hydrocarbon solvents such as toluene and xylene; nitrile solvents such as acetonitrile; ether solvents such as tetrahydrofuran and dimethoxyethane; and Chlorine-containing solvents such as chloroform and chlorobenzene. These solvents may be used alone or in combination of two or more kinds.

於組合物包含溶劑之情形時,溶劑之含有比率較佳為相對於組合物之總量為50質量%以上98質量%以下。換言之,組合物中之固形物成分之含有比率較佳為2質量%以上50質量%以下。若該固形物成分為50質量%以下,則組合物之黏度變低,由組合物獲得之膜之厚度變得大致均勻,存在該膜上不易產生不均之傾向。該固形物成分之含有比率可考慮到所欲製造之膜之厚度來決定。When the composition contains a solvent, the content ratio of the solvent is preferably 50% by mass or more and 98% by mass or less with respect to the total amount of the composition. In other words, the solid content in the composition is preferably 2% by mass or more and 50% by mass or less. If the solid content is 50% by mass or less, the viscosity of the composition becomes low, the thickness of the film obtained from the composition becomes substantially uniform, and there is a tendency that unevenness is not easily generated on the film. The content ratio of the solid component can be determined in consideration of the thickness of the film to be manufactured.

(聚合起始劑) 聚合起始劑係能夠使聚合性液晶化合物之聚合反應開始之化合物。聚合起始劑就能夠於更低溫條件下使聚合反應開始之方面而言較佳為光聚合起始劑。具體而言,可列舉藉由光之作用能夠產生活性自由基或酸之光聚合起始劑,其中,較佳為藉由光之作用產生自由基之光聚合起始劑。(Polymerization initiator) The polymerization initiator is a compound capable of starting the polymerization reaction of the polymerizable liquid crystal compound. The polymerization initiator is preferably a photopolymerization initiator in terms of being able to start the polymerization reaction under lower temperature conditions. Specifically, photopolymerization initiators capable of generating active radicals or acids by the action of light can be cited. Among them, photopolymerization initiators that generate free radicals by the action of light are preferred.

作為聚合起始劑,可列舉:安息香化合物、二苯甲酮化合物、苯烷酮化合物、醯基氧化膦化合物、三𠯤化合物、錪鹽、及鋶鹽等。聚合起始劑可視目的等自公知之聚合起始劑適當選擇。又,聚合起始劑可單獨使用1種或將2種以上組合使用。As the polymerization initiator, a benzoin compound, a benzophenone compound, a benzophenone compound, an oxyphosphine oxide compound, a tris compound, an iodonium salt, a sulfonium salt, etc. can be mentioned. The polymerization initiator may be appropriately selected from known polymerization initiators depending on the purpose and the like. Moreover, a polymerization initiator can be used individually by 1 type or in combination of 2 or more types.

作為安息香化合物,可列舉:安息香、安息香甲醚、安息香乙醚、安息香異丙醚及安息香異丁醚等。As a benzoin compound, benzoin, benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, benzoin isobutyl ether, etc. are mentioned.

作為二苯甲酮化合物,可列舉:二苯甲酮、鄰苯甲醯苯甲酸甲酯、4-苯基二苯甲酮、4-苯甲醯基-4'-甲基二苯硫醚、3,3,4,4-四(第三丁基過氧基羰基)二苯甲酮及2,4,6-三甲基二苯甲酮等。Examples of the benzophenone compound include benzophenone, methyl phthalate, 4-phenylbenzophenone, 4-benzophenone-4'-methyl diphenyl sulfide, 3,3,4,4-Tetra(tert-butylperoxycarbonyl)benzophenone and 2,4,6-trimethylbenzophenone, etc.

作為苯烷酮化合物,可列舉:二乙氧基苯乙酮、2-甲基-2-𠰌啉基-1-(4-甲硫基苯基)丙烷-1-酮、2-苄基-2-二甲胺基-1-(4-𠰌啉基苯基)丁烷-1-酮、2-羥基-2-甲基-1-苯基丙烷-1-酮、1,2-二苯基-2,2-二甲氧基乙烷-1-酮、2-羥基-2-甲基-1-[4-(2-羥基乙氧基)苯基]丙烷-1-酮、1-羥基環己基苯基酮及2-羥基-2-甲基-1-[4-(1-甲基乙烯基)苯基]丙烷-1-酮之低聚物等。Examples of the phenanone compound include diethoxyacetophenone, 2-methyl-2-𠰌line-1-(4-methylthiophenyl)propan-1-one, 2-benzyl- 2-Dimethylamino-1-(4-𠰌linephenyl)butan-1-one, 2-hydroxy-2-methyl-1-phenylpropan-1-one, 1,2-diphenyl Base-2,2-dimethoxyethane-1-one, 2-hydroxy-2-methyl-1-[4-(2-hydroxyethoxy)phenyl]propan-1-one, 1- Hydroxycyclohexyl phenyl ketone and oligomers of 2-hydroxy-2-methyl-1-[4-(1-methylvinyl)phenyl]propan-1-one, etc.

作為醯基氧化膦化合物,可列舉2,4,6-三甲基苯甲醯基二苯基氧化膦及雙(2,4,6-三甲基苯甲醯基)苯基氧化膦等。As the phosphine oxide compound, 2,4,6-trimethylbenzyldiphenylphosphine oxide, bis(2,4,6-trimethylbenzyl)phenylphosphine oxide, and the like can be mentioned.

作為三𠯤化合物,可列舉:2,4-雙(三氯甲基)-6-(4-甲氧基苯基)-1,3,5-三𠯤、2,4-雙(三氯甲基)-6-(4-甲氧基萘基)-1,3,5-三𠯤、2,4-雙(三氯甲基)-6-(4-甲氧基苯乙烯基)-1,3,5-三𠯤、2,4-雙(三氯甲基)-6-[2-(5-甲基呋喃-2-基)乙烯基]-1,3,5-三𠯤、2,4-雙(三氯甲基)-6-[2-(呋喃-2-基)乙烯基]-1,3,5-三𠯤、2,4-雙(三氯甲基)-6-[2-(4-二乙基胺基-2-甲基苯基)乙烯基]-1,3,5-三𠯤及2,4-雙(三氯甲基)-6-[2-(3,4-二甲氧基苯基)乙烯基]-1,3,5-三𠯤等。Examples of the tris compound include: 2,4-bis(trichloromethyl)-6-(4-methoxyphenyl)-1,3,5-tris, 2,4-bis(trichloromethyl) Yl)-6-(4-methoxynaphthyl)-1,3,5-tris, 2,4-bis(trichloromethyl)-6-(4-methoxystyryl)-1 ,3,5-tris𠯤、2,4-bis(trichloromethyl)-6-[2-(5-methylfuran-2-yl)vinyl]-1,3,5-tris𠯤、2 ,4-Bis(trichloromethyl)-6-[2-(furan-2-yl)vinyl]-1,3,5-tris, 2,4-bis(trichloromethyl)-6- [2-(4-Diethylamino-2-methylphenyl)vinyl]-1,3,5-tris and 2,4-bis(trichloromethyl)-6-[2-( 3,4-Dimethoxyphenyl)vinyl]-1,3,5-tri 𠯤 and the like.

作為錪鹽及鋶鹽,例如可列舉下述式所表示之鹽等。Examples of the sulphur salt and sulphur salt include salts represented by the following formulae.

[化28]

Figure 02_image057
[化28]
Figure 02_image057

作為聚合起始劑,亦可使用市售品。作為市售之聚合起始劑,可列舉:Irgacure(註冊商標)907、184、651、819、250、及369(BASF JAPAN股份有限公司製造);Seikuol(註冊商標)BZ、Z、及BEE(精工化學股份有限公司製造);kayacure(註冊商標)BP100、及UVI-6992(Dow Chemical股份有限公司製造);Adeka Optomer SP-152、及SP-170(ADEKA股份有限公司製造);TAZ-A、及TAZ-PP(Nihon SiberHegner股份有限公司製造);以及TAZ-104(SANWA CHEMICAL股份有限公司製造)等。As the polymerization initiator, a commercially available product may also be used. Commercially available polymerization initiators include: Irgacure (registered trademark) 907, 184, 651, 819, 250, and 369 (manufactured by BASF JAPAN Co., Ltd.); Seikuol (registered trademark) BZ, Z, and BEE ( Seiko Chemical Co., Ltd.); kayacure (registered trademark) BP100, and UVI-6992 (manufactured by Dow Chemical Co., Ltd.); Adeka Optomer SP-152, and SP-170 (manufactured by ADEKA Co., Ltd.); TAZ-A, And TAZ-PP (manufactured by Nihon SiberHegner Co., Ltd.); and TAZ-104 (manufactured by SANWA CHEMICAL Co., Ltd.), etc.

於組合物含有聚合起始劑之情形時,其含量只要視該組合物中所包含之聚合性液晶化合物之種類及其量適當決定即可。聚合起始劑之含量相對於聚合性液晶化合物100質量份例如為0.001質量份以上、0.01質量份以上或0.1質量份以上,例如為30質量%以下、10質量%以下或8質量%以下。又,聚合起始劑之含量相對於聚合性液晶化合物100質量份較佳為0.001質量份以上30質量份以下,更佳為0.01質量份以上10質量份以下,進而較佳為0.1質量份以上8質量份以下。若聚合性起始劑之含量為上述範圍內,則能夠於不干擾聚合性液晶化合物之配向之情況下使之聚合。When the composition contains a polymerization initiator, its content may be appropriately determined depending on the type and amount of the polymerizable liquid crystal compound contained in the composition. The content of the polymerization initiator relative to 100 parts by mass of the polymerizable liquid crystal compound is, for example, 0.001 part by mass or more, 0.01 part by mass or more, or 0.1 part by mass or more, for example, 30% by mass or less, 10% by mass or less, or 8% by mass or less. In addition, the content of the polymerization initiator relative to 100 parts by mass of the polymerizable liquid crystal compound is preferably 0.001 parts by mass or more and 30 parts by mass or less, more preferably 0.01 parts by mass or more and 10 parts by mass or less, and still more preferably 0.1 parts by mass or more. Parts by mass or less. If the content of the polymerizable initiator is within the above range, the polymerizable liquid crystal compound can be polymerized without disturbing the alignment of the polymerizable liquid crystal compound.

(光敏劑) 於組合物含有光聚合起始劑之情形時,組合物較佳為含有光敏劑之至少1種即可。藉由組合物含有光聚合起始劑及光敏劑,存在可進一步促進聚合性液晶化合物之聚合反應之傾向。作為該光敏劑,可列舉:𠮿酮及9-氧硫𠮿

Figure 109124436-A0304-12-01
等𠮿酮化合物(例如2,4-二乙基9-氧硫𠮿
Figure 109124436-A0304-12-01
、2-異丙基9-氧硫𠮿
Figure 109124436-A0304-12-01
);蒽及含烷氧基之蒽(例如二丁氧基蒽)等蒽化合物;啡噻𠯤及紅螢烯等。光敏劑可單獨使用1種或將2種以上組合使用。(Photosensitizer) When the composition contains a photopolymerization initiator, the composition preferably contains at least one type of photosensitizer. Since the composition contains a photopolymerization initiator and a photosensitizer, there is a tendency that the polymerization reaction of the polymerizable liquid crystal compound can be further promoted. Examples of the photosensitizer include: ketone and 9-oxysulfur
Figure 109124436-A0304-12-01
And other ketone compounds (such as 2,4-diethyl 9-oxysulfur)
Figure 109124436-A0304-12-01
, 2-isopropyl 9-oxysulfur 𠮿
Figure 109124436-A0304-12-01
); anthracene compounds such as anthracene and alkoxy-containing anthracene (such as dibutoxyanthracene); phenanthrene and fluorene. The photosensitizer can be used alone or in combination of two or more.

於組合物包含光敏劑之情形時,組合物中之光敏劑之含量只要視光聚合起始劑及聚合性液晶化合物之種類及其量適當決定即可。組合物中之光敏劑之含量相對於聚合性液晶化合物100質量份較佳為0.1質量份以上30質量份以下,更佳為0.5質量份以上10質量份以下,進而較佳為0.5質量份以上8質量份以下。When the composition contains a photosensitizer, the content of the photosensitizer in the composition may be appropriately determined depending on the type and amount of the photopolymerization initiator and the polymerizable liquid crystal compound. The content of the photosensitizer in the composition relative to 100 parts by mass of the polymerizable liquid crystal compound is preferably 0.1 part by mass or more and 30 parts by mass or less, more preferably 0.5 part by mass or more and 10 parts by mass or less, and still more preferably 0.5 part by mass or more. Parts by mass or less.

(聚合抑制劑) 組合物亦可包含聚合抑制劑之至少1種。作為聚合抑制劑,例如可列舉:對苯二酚、含烷氧基之對苯二酚、含烷氧基之鄰苯二酚(例如丁基鄰苯二酚)、鄰苯三酚、2,2,6,6-四甲基-1-哌啶氧基自由基等自由基捕捉劑;苯硫酚類;β-萘胺類及β-萘酚類等。(Polymerization inhibitor) The composition may also contain at least one type of polymerization inhibitor. Examples of polymerization inhibitors include hydroquinone, alkoxy-containing hydroquinone, alkoxy-containing catechol (for example, butylcatechol), pyrogallol, 2, Radical scavengers such as 2,6,6-tetramethyl-1-piperidinyloxy free radicals; thiophenols; β-naphthylamines and β-naphthols, etc.

藉由組合物包含聚合抑制劑,能夠控制聚合性液晶化合物之聚合反應之進行程度。By including the polymerization inhibitor in the composition, the progress of the polymerization reaction of the polymerizable liquid crystal compound can be controlled.

於組合物包含聚合抑制劑之情形時,組合物中之聚合抑制劑之含量相對於聚合性液晶化合物100質量份較佳為0.1質量份以上30質量份以下,更佳為0.5質量份以上10質量份以下,進而較佳為0.5質量份以上8質量份以下。When the composition contains a polymerization inhibitor, the content of the polymerization inhibitor in the composition relative to 100 parts by mass of the polymerizable liquid crystal compound is preferably 0.1 part by mass or more and 30 parts by mass or less, more preferably 0.5 part by mass or more and 10 parts by mass Parts or less, more preferably 0.5 parts by mass or more and 8 parts by mass or less.

(調平劑) 組合物亦可包含調平劑之至少1種。調平劑具有調整組合物之流動性、使藉由塗佈該組合物而獲得之塗膜更平坦之功能,具體而言,可列舉界面活性劑。作為調平劑,較佳為選自由以聚丙烯酸酯化合物為主成分之調平劑及以含氟原子之化合物為主成分之調平劑所組成之群中之至少1種。調平劑可單獨使用1種或將2種以上組合使用。(Leveling agent) The composition may also include at least one leveling agent. The leveling agent has the function of adjusting the fluidity of the composition and making the coating film obtained by applying the composition flatter. Specifically, a surfactant can be mentioned. The leveling agent is preferably at least one selected from the group consisting of a leveling agent having a polyacrylate compound as a main component and a leveling agent having a fluorine atom-containing compound as a main component. The leveling agent can be used individually by 1 type or in combination of 2 or more types.

作為以聚丙烯酸酯化合物為主成分之調平劑,例如可列舉:「BYK-350」、「BYK-352」、「BYK-353」、「BYK-354」、「BYK-355」、「BYK-358N」、「BYK-361N」、「BYK-380」、「BYK-381」及「BYK-392」(BYK Chemie公司)等。As a leveling agent with polyacrylate compound as the main component, for example, "BYK-350", "BYK-352", "BYK-353", "BYK-354", "BYK-355", "BYK -358N", "BYK-361N", "BYK-380", "BYK-381" and "BYK-392" (BYK Chemie), etc.

作為以含氟原子之化合物為主成分之調平劑,例如可列舉:「MEGAFAC(註冊商標)R-08」、「MEGAFAC(註冊商標)R-30」、「MEGAFAC(註冊商標)R-90」、「MEGAFAC(註冊商標)F-410」、「MEGAFAC(註冊商標)F-411」、「MEGAFAC(註冊商標)F-443」、「MEGAFAC(註冊商標)F-445」、「MEGAFAC(註冊商標)F-470」、「MEGAFAC(註冊商標)F-471」、「MEGAFAC(註冊商標)F-477」、「MEGAFAC(註冊商標)F-479」、「MEGAFAC(註冊商標)F-482」及「MEGAFAC(註冊商標)F-483」(DIC(股));「Surflon(註冊商標)S-381」、「Surflon(註冊商標)S-382」、「Surflon(註冊商標)S-383」、「Surflon (註冊商標)S-393」、「Surflon(註冊商標)SC-101」、「Surflon(註冊商標)SC-105」、「KH-40」及「SA-100」(AGC SEIMI CHEMICAL(股));「E1830」、「E5844」(Daikin Fine Chemical Laboratory(股));「Eftop EF301」、「Eftop EF303」、「Eftop EF351」及「Eftop EF352」(Mitsubishi Materials Electronic Chemicals股份有限公司製造)等。As a leveling agent mainly composed of a compound containing a fluorine atom, for example, "MEGAFAC (registered trademark) R-08", "MEGAFAC (registered trademark) R-30", "MEGAFAC (registered trademark) R-90" ", "MEGAFAC (registered trademark) F-410", "MEGAFAC (registered trademark) F-411", "MEGAFAC (registered trademark) F-443", "MEGAFAC (registered trademark) F-445", "MEGAFAC (registered trademark) Trademark) F-470", "MEGAFAC (registered trademark) F-471", "MEGAFAC (registered trademark) F-477", "MEGAFAC (registered trademark) F-479", "MEGAFAC (registered trademark) F-482" And "MEGAFAC (registered trademark) F-483" (DIC (shares)); "Surflon (registered trademark) S-381", "Surflon (registered trademark) S-382", "Surflon (registered trademark) S-383" , "Surflon (registered trademark) S-393", "Surflon (registered trademark) SC-101", "Surflon (registered trademark) SC-105", "KH-40" and "SA-100" (AGC SEIMI CHEMICAL ( Stock)); "E1830", "E5844" (Daikin Fine Chemical Laboratory (stock)); "Eftop EF301", "Eftop EF303", "Eftop EF351" and "Eftop EF352" (manufactured by Mitsubishi Materials Electronic Chemicals Co., Ltd.) Wait.

於組合物包含調平劑之情形時,調平劑之含量相對於聚合性液晶化合物及高分子化合物之合計量100質量份較佳為0.05質量份以上5質量份以下,更佳為0.05質量份以上3質量份以下。若調平劑之含量為上述範圍內,則容易使聚合性液晶化合物水平配向,且不易產生不均,存在可獲得更平滑之膜例如偏光膜之傾向。When the composition contains a leveling agent, the content of the leveling agent is preferably 0.05 parts by mass or more and 5 parts by mass or less, more preferably 0.05 parts by mass relative to 100 parts by mass of the total amount of the polymerizable liquid crystal compound and the polymer compound. The above 3 parts by mass or less. If the content of the leveling agent is within the above range, it is easy to align the polymerizable liquid crystal compound horizontally, and unevenness is unlikely to occur, and there is a tendency to obtain a smoother film such as a polarizing film.

若調平劑之含量為上述範圍內,則容易使聚合性液晶化合物或聚合性液晶化合物之聚合物等液晶性高分子化合物水平配向,且存在所獲得之膜更平滑之傾向。若調平劑之含量相對於聚合性液晶化合物超過上述範圍,則存在所獲得之膜產生不均之情況。If the content of the leveling agent is within the above range, it is easy to horizontally align liquid crystal polymer compounds such as polymerizable liquid crystal compounds or polymers of polymerizable liquid crystal compounds, and the obtained film tends to be smoother. If the content of the leveling agent exceeds the above range with respect to the polymerizable liquid crystal compound, unevenness may occur in the obtained film.

組合物可含有除上述以外之其他添加劑。作為其他添加劑,例如可列舉:脫模劑、穩定劑、抗氧化劑、上藍劑等著色劑、阻燃劑及潤滑劑等。於組合物含有其他添加劑之情形時,其他添加劑之含量相對於組合物之固形物成分較佳為超過0%且20質量%以下,更佳為超過0%且10質量%以下。The composition may contain other additives in addition to the above. Examples of other additives include coloring agents such as mold release agents, stabilizers, antioxidants, and bluing agents, flame retardants, lubricants, and the like. When the composition contains other additives, the content of the other additives relative to the solid content of the composition is preferably more than 0% and 20% by mass or less, more preferably more than 0% and 10% by mass or less.

<膜> 本實施方式之膜係以式(1)所表示之化合物作為形成材料而獲得者,例如可構成偏光膜。即,膜可為包含式(1)所表示之化合物之膜,亦可為包含含有式(1)所表示之化合物之組合物之膜、或含有式(1)所表示之化合物之組合物之硬化物。包含式(1)所表示之化合物之膜可藉由將式(1)所表示之化合物賦予至基材上進行成膜而形成。又,包含含有式(1)所表示之化合物之組合物之膜可藉由將組合物賦予至基材上進行成膜而形成。又,於包含式(1)所表示之化合物之組合物包含聚合性液晶化合物之情形時,包含使該聚合性液晶化合物聚合而獲得之硬化物之膜可藉由將組合物賦予至基材上進行成膜之後使該聚合性液晶化合物進行聚合並硬化而形成。<Membrane> The film of this embodiment is obtained by using the compound represented by formula (1) as a forming material, and can constitute a polarizing film, for example. That is, the film may be a film containing a compound represented by formula (1), a film containing a composition containing a compound represented by formula (1), or a composition containing a compound represented by formula (1) Hardened object. The film containing the compound represented by the formula (1) can be formed by applying the compound represented by the formula (1) to a substrate and forming a film. In addition, a film including a composition containing the compound represented by formula (1) can be formed by applying the composition to a substrate and forming a film. In addition, when the composition containing the compound represented by the formula (1) contains a polymerizable liquid crystal compound, a film containing a cured product obtained by polymerizing the polymerizable liquid crystal compound can be provided by applying the composition to a substrate After film formation, the polymerizable liquid crystal compound is polymerized and cured to form it.

<積層體> 本實施方式之積層體包含以式(1)所表示之化合物作為形成材料之膜。積層體可具備基材、及配置於基材上之以式(1)所表示之化合物作為形成材料之膜。積層體例如可構成偏光板。積層體可藉由如下方式而製造:將包含式(1)所表示之化合物之組合物賦予至基材上,並使所賦予之組合物成膜。<Laminated body> The laminate of the present embodiment includes a film using the compound represented by formula (1) as a forming material. The layered product may include a substrate and a film formed on the substrate and the compound represented by formula (1) as a forming material. The laminate may constitute a polarizing plate, for example. The laminate can be produced by applying a composition containing the compound represented by formula (1) to a substrate, and forming a film of the applied composition.

本實施方式之積層體可藉由包括下述步驟A及步驟B、及視需要之步驟C之製造方法而製造。於組合物除式(1)所表示之化合物以外包含液晶性高分子化合物之情形時,較佳為進而於步驟B中使液晶性高分子化合物配向。於組合物除式(1)所表示之化合物以外包含聚合性液晶化合物之情形時,較佳為包含步驟A、B及C。The layered body of this embodiment can be manufactured by a manufacturing method including the following steps A and B, and optionally a step C. When the composition contains a liquid crystal polymer compound in addition to the compound represented by formula (1), it is preferable to further align the liquid crystal polymer compound in step B. When the composition includes a polymerizable liquid crystal compound in addition to the compound represented by formula (1), it is preferable to include steps A, B, and C.

可藉由包括如下步驟之製造方法製造積層體: 步驟A:於基材之表面塗佈至少包含化合物(1)之組合物形成塗佈膜; 步驟B:進行加熱以將溶劑去除並且使所形成之塗佈膜中所包含之液晶性高分子化合物及聚合性液晶化合物之至少一者與化合物(1)配向; 步驟C:藉由對進行過配向之聚合性液晶化合物照射活性能量線而使聚合性液晶化合物進行聚合。The laminated body can be manufactured by a manufacturing method including the following steps: Step A: coating a composition containing at least compound (1) on the surface of the substrate to form a coating film; Step B: heating to remove the solvent and align at least one of the liquid crystal polymer compound and the polymerizable liquid crystal compound contained in the formed coating film with the compound (1); Step C: Polymerize the polymerizable liquid crystal compound by irradiating the aligned polymerizable liquid crystal compound with active energy rays.

(步驟A) 基材為玻璃基材、樹脂基材等之任一者均可,較佳為樹脂基材。藉由使用包含樹脂之膜基材,能夠獲得較薄之積層體。(Step A) The substrate may be any of a glass substrate, a resin substrate, etc., but a resin substrate is preferred. By using a film substrate containing resin, a thinner laminate can be obtained.

樹脂基材較佳為透明樹脂基材。透明樹脂基材意指可使光、特別是可見光透過之具有透光性之基材,透光性係指對跨及波長380 nm以上780 nm以下之波長範圍之光線之視感度補正透過率成為80%以上之特性。The resin substrate is preferably a transparent resin substrate. Transparent resin substrate refers to a transparent substrate that can transmit light, especially visible light. Transparency refers to the visual sensitivity of light that spans the wavelength range from 380 nm to 780 nm, and the transmittance becomes More than 80% characteristics.

作為構成基材之樹脂,例如可列舉:聚乙烯、聚丙烯、降𦯉烯系聚合物等聚烯烴;環狀烯烴系樹脂;聚乙烯醇;聚對苯二甲酸乙二酯;聚甲基丙烯酸酯;聚丙烯酸酯;三乙醯纖維素、二乙醯纖維素、及乙酸丙酸纖維素等纖維素酯;聚萘二甲酸乙二酯;聚碳酸酯;聚碸;聚醚碸;聚醚酮;聚苯硫醚;聚苯醚等。較佳為選自由纖維素酯、環狀烯烴系樹脂、聚碳酸酯、聚醚碸、聚對苯二甲酸乙二酯、或聚甲基丙烯酸酯所組成之群中之至少1種。Examples of the resin constituting the substrate include: polyolefins such as polyethylene, polypropylene, norene-based polymers; cyclic olefin-based resins; polyvinyl alcohol; polyethylene terephthalate; polymethacrylic acid Esters; polyacrylates; cellulose esters such as triacetyl cellulose, diethyl cellulose, and cellulose acetate propionate; polyethylene naphthalate; polycarbonate; polyether; polyether; polyether Ketones; polyphenylene sulfide; polyphenylene ether, etc. Preferably, it is at least one selected from the group consisting of cellulose ester, cyclic olefin resin, polycarbonate, polyether agglomerate, polyethylene terephthalate, or polymethacrylate.

基材之厚度只要為能夠進行實用性之操作之程度,則較佳為厚度較薄,但若過薄,則存在強度降低、加工性較差之情形。基材之厚度通常為5 μm以上300 μm以下,較佳為20 μm以上200 μm以下。As long as the thickness of the base material is such that it can be operated practically, it is preferably thinner, but if it is too thin, the strength may decrease and the workability may be poor. The thickness of the substrate is usually 5 μm or more and 300 μm or less, preferably 20 μm or more and 200 μm or less.

(步驟B) 於上述組合物包含溶劑之情形時,通常自所形成之塗佈膜將溶劑去除。作為溶劑之去除方法,可列舉:自然乾燥法、通風乾燥法、加熱乾燥及減壓乾燥法等。(Step B) In the case where the above-mentioned composition contains a solvent, the solvent is usually removed from the formed coating film. Examples of the solvent removal method include natural drying method, ventilation drying method, heat drying and reduced pressure drying method.

於所形成之塗佈膜中包含液晶性高分子化合物及聚合性液晶化合物之情形時,通常可藉由如下方式進行配向而形成液晶相:加熱至轉變為溶液狀態之溫度以上,繼而冷卻至液晶配向之溫度。When the formed coating film contains a liquid crystal polymer compound and a polymerizable liquid crystal compound, the liquid crystal phase can usually be formed by aligning in the following way: heating to a temperature above the temperature at which it turns into a solution state, and then cooling to liquid crystal The temperature of the alignment.

於所形成之塗佈膜中包含液晶性高分子化合物及聚合性液晶化合物之情形時,液晶性高分子化合物及聚合性液晶化合物進行配向之溫度只要預先藉由使用包含該液晶性高分子化合物及該聚合性液晶化合物之組合物之質構觀察等求出即可。又,亦可同時進行溶劑之去除及液晶配向。作為此時之溫度,亦取決於去除之溶劑或聚合性液晶化合物之種類,但較佳為50℃以上200℃以下之範圍,於基材為樹脂基材之情形時,更佳為80℃以上130℃以下之範圍。When the formed coating film contains a liquid crystal polymer compound and a polymerizable liquid crystal compound, the temperature at which the liquid crystal polymer compound and the polymerizable liquid crystal compound are aligned should be preliminarily used to include the liquid crystal polymer compound and The composition of the polymerizable liquid crystal compound may be obtained by observing the texture and the like. In addition, solvent removal and liquid crystal alignment can also be performed at the same time. The temperature at this time also depends on the type of solvent or polymerizable liquid crystal compound to be removed, but it is preferably 50°C or more and 200°C or less, and when the substrate is a resin substrate, it is more preferably 80°C or more The range below 130°C.

(步驟C) 於所形成之塗佈膜中包含聚合性液晶化合物之情形時,藉由對進行過配向之聚合性液晶化合物照射活性能量線,使聚合性液晶化合物聚合。(Step C) When a polymerizable liquid crystal compound is included in the formed coating film, the polymerizable liquid crystal compound is polymerized by irradiating the aligned polymerizable liquid crystal compound with active energy rays.

藉由使進行過配向之聚合性液晶化合物進行聚合,可獲得包含以配向之狀態聚合之聚合性液晶化合物、及與該聚合性液晶化合物一起配向之化合物(1)之偏光膜。By polymerizing the aligned polymerizable liquid crystal compound, a polarizing film including the polymerizable liquid crystal compound polymerized in an aligned state and the compound (1) aligned together with the polymerizable liquid crystal compound can be obtained.

包含於保持層列型液晶相之狀態下聚合之聚合性液晶化合物之偏光膜與先前之主客型偏光膜,即於保持向列型液晶相之狀態下使聚合性液晶化合物等進行聚合所獲得之偏光膜相比,偏光性能較高,又,與僅塗佈二色性色素或溶致性液晶型之液晶化合物而成之偏光膜相比,偏光性能及強度優異。A polarizing film containing a polymerizable liquid crystal compound polymerized while maintaining a smectic liquid crystal phase and the previous host-guest polarizing film, which is obtained by polymerizing a polymerizable liquid crystal compound while maintaining a nematic liquid crystal phase. Compared with the polarizing film, the polarizing performance is higher, and compared with the polarizing film formed by coating only the dichroic dye or the lyotropic liquid crystal compound, the polarizing performance and strength are superior.

作為活性能量線之放射源,只要為產生紫外線、電子束、X射線等之放射源即可。較佳為低壓水銀燈、中壓水銀燈、高壓水銀燈、超高壓水銀燈、化學燈、黑光燈、微波激發水銀燈、金屬鹵化物燈等在波長400 nm以下具有發光分佈之光源。As a radiation source of active energy rays, any radiation source that generates ultraviolet rays, electron beams, X-rays, etc. may be sufficient. It is preferably a low-pressure mercury lamp, a medium-pressure mercury lamp, a high-pressure mercury lamp, an ultra-high-pressure mercury lamp, a chemical lamp, a black light lamp, a microwave-excited mercury lamp, a metal halide lamp and other light sources with a luminous distribution below 400 nm.

<顯示裝置> 顯示裝置係具有顯示元件之裝置,且係包含發光元件或發光裝置作為發光源之裝置。作為具備本實施方式之膜、較佳為偏光膜之顯示裝置,例如可列舉:液晶顯示裝置、有機電致發光(EL)顯示裝置、無機電致發光(EL)顯示裝置、電子發射顯示裝置(例如,場發射顯示裝置(FED)、表面傳導電子發射顯示裝置(SED))、電子紙(使用電子油墨、電泳元件等之顯示裝置)、電漿顯示裝置、投射型顯示裝置(例如,柵狀光閥(GLV)顯示裝置、具有數位微鏡裝置(DMD)之顯示裝置)、及壓電陶瓷顯示器等。液晶顯示裝置包含透過型液晶顯示裝置、半透過型液晶顯示裝置、反射型液晶顯示裝置、直視型液晶顯示裝置、及投影型液晶顯示裝置等之任一者。該等顯示裝置可為顯示二維圖像之顯示裝置,亦可為顯示三維圖像之立體顯示裝置。<Display device> The display device is a device having a display element, and is a device including a light-emitting element or a light-emitting device as a light-emitting source. As a display device having the film of this embodiment, preferably a polarizing film, for example, a liquid crystal display device, an organic electroluminescence (EL) display device, an inorganic electroluminescence (EL) display device, an electron emission display device ( For example, field emission display devices (FED), surface conduction electron emission display devices (SED), electronic paper (display devices using electronic ink, electrophoretic elements, etc.), plasma display devices, projection display devices (e.g., grid-shaped Light valve (GLV) display device, digital micro-mirror device (DMD) display device), and piezoelectric ceramic display, etc. The liquid crystal display device includes any one of a transmissive liquid crystal display device, a semi-transmissive liquid crystal display device, a reflective liquid crystal display device, a direct-view liquid crystal display device, and a projection liquid crystal display device. The display devices can be display devices that display two-dimensional images, or stereoscopic display devices that display three-dimensional images.

本實施方式之膜(較佳為偏光膜)特別是能夠有效地用於液晶顯示裝置、有機電致發光(EL)顯示裝置、及無機電致發光(EL)顯示裝置。上述有機EL顯示裝置至少具備本實施方式之膜較佳為偏光膜及有機EL元件而構成。有機EL元件可使用公知之構成之元件。The film (preferably a polarizing film) of this embodiment can be effectively used in liquid crystal display devices, organic electroluminescence (EL) display devices, and inorganic electroluminescence (EL) display devices, in particular. The above-mentioned organic EL display device is preferably configured to include at least the film of the present embodiment, a polarizing film and an organic EL element. The organic EL device can use a device having a well-known structure.

作為具有本實施方式之膜較佳為偏光膜及1/4波長板之積層體之圓偏光板特別是能夠有效地用於有機電致發光(EL)顯示裝置及無機電致發光(EL)顯示裝置。上述有機EL顯示裝置至少具備本實施方式之積層體較佳為圓偏光板及有機EL元件而構成。As the film of this embodiment, it is preferable to use a circularly polarizing plate of a laminate of a polarizing film and a quarter-wavelength plate, and it is particularly effective for organic electroluminescence (EL) display devices and inorganic electroluminescence (EL) displays. Device. The above-mentioned organic EL display device includes at least the layered body of the present embodiment, and is preferably constituted by a circularly polarizing plate and an organic EL element.

於將本實施方式之膜較佳為偏光膜用於液晶顯示裝置之情形時,該膜可於液晶單元之外部具備,亦可於液晶單元之內部具備。液晶單元至少具備本實施方式之膜較佳為偏光膜、液晶層及基體而構成。 [實施例]When the film of this embodiment is preferably a polarizing film used in a liquid crystal display device, the film may be provided outside the liquid crystal cell, or may be provided inside the liquid crystal cell. The liquid crystal cell is preferably composed of at least the film of the present embodiment, which is a polarizing film, a liquid crystal layer, and a substrate. [Example]

以下,藉由實施例進一步具體地說明本發明,但本發明並不受該等實施例所限定。Hereinafter, the present invention will be explained in more detail through examples, but the present invention is not limited by these examples.

實施例1:化合物(2-2)之合成 為了合成化合物(2-2),首先合成化合物(2-2-a)。繼而,使化合物(2-2-a)與化合物(2-1-c)進行鈴木偶合而獲得化合物(2-2)。再者,化合物(2-1-c)係經由化合物(2-1-b)而合成。Example 1: Synthesis of compound (2-2) In order to synthesize compound (2-2), compound (2-2-a) is synthesized first. Then, the compound (2-2-a) and the compound (2-1-c) are subjected to Suzuki coupling to obtain the compound (2-2). In addition, compound (2-1-c) is synthesized via compound (2-1-b).

化合物(2-2-a)之合成 於EDC・HCl(1-乙基-3-(3-二甲胺基丙基)碳二醯亞胺鹽酸鹽之縮寫;1.21 g、6.00 mmol)與DMAP(N,N-二甲胺基吡啶之縮寫;0.074 g、0.60 mmol)之二氯甲烷(60 mL)溶液中依序加入正己醇(1.20 mL、9.6 mmol)、及4-溴-2,3,5,6-四氟苯甲酸(1.64 g、6.00 mmol)。於室溫下攪拌5小時後,用水將反應溶液洗淨,繼而用飽和鹽水進行洗淨,並用硫酸鎂進行乾燥,用蒸發器進行濃縮,藉此獲得化合物(2-2-a)(1.69 g、產率79%)。Synthesis of compound (2-2-a) The abbreviation for EDC·HCl (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride; 1.21 g, 6.00 mmol) and DMAP (N,N-dimethylaminopropyl) Abbreviation for pyridine; 0.074 g, 0.60 mmol) in dichloromethane (60 mL) was added n-hexanol (1.20 mL, 9.6 mmol) and 4-bromo-2,3,5,6-tetrafluorobenzoic acid in sequence (1.64 g, 6.00 mmol). After stirring at room temperature for 5 hours, the reaction solution was washed with water, then with saturated brine, dried with magnesium sulfate, and concentrated with an evaporator to obtain compound (2-2-a) (1.69 g) , Yield 79%).

[化29]

Figure 02_image059
[化29]
Figure 02_image059

化合物(2-1-b)之合成 將4-溴苯胺(13.2 g、77.6 mmol)、35%鹽酸(22.0 mL,249 mmol)、及水(200 mL)加以混合並冷卻至0℃至5℃。向其中滴加亞硝酸鈉(13.0 g、189 mmol)之水(26 mL)溶液。其後,一面維持0℃至5℃一面攪拌30分鐘,並進而添加醯胺硫酸(11.0 g,113 mmol)而製備重氮液。另一方面,將N,N-二甲基苯胺(14.0 mL、111 mmol)、乙酸鈉(24.8 g,302 mmol)、甲醇(200 mL)、及水(100 mL)加以混合並冷卻至0℃至5℃,滴加剛才所製備之重氮液總量。滴加結束後升溫至常溫,過濾分離出所析出之固體而獲得化合物(2-1-b)(21.0 g、產率90%)。Synthesis of compound (2-1-b) Mix 4-bromoaniline (13.2 g, 77.6 mmol), 35% hydrochloric acid (22.0 mL, 249 mmol), and water (200 mL) and cool to 0°C to 5°C. A solution of sodium nitrite (13.0 g, 189 mmol) in water (26 mL) was added dropwise. Then, it stirred for 30 minutes while maintaining 0 degreeC to 5 degreeC, and further added amidosulfuric acid (11.0 g, 113 mmol), and prepared the diazonium liquid. On the other hand, N,N-dimethylaniline (14.0 mL, 111 mmol), sodium acetate (24.8 g, 302 mmol), methanol (200 mL), and water (100 mL) were mixed and cooled to 0°C To 5°C, add dropwise the total amount of diazonium solution just prepared. After the dropwise addition, the temperature was raised to normal temperature, and the precipitated solid was separated by filtration to obtain compound (2-1-b) (21.0 g, yield 90%).

[化30]

Figure 02_image061
[化30]
Figure 02_image061

化合物(2-1-c)之合成 將化合物(2-1-b)(18.3 g、60.0 mmol)之THF(450 mL)溶液冷卻至-78℃,向其中滴加1.57 M之正丁基鋰己烷溶液(38.0 mL、59.7 mmol)。其後,一面維持-78℃一面攪拌30分鐘,進而滴加iPrOBpin(2-異丙氧基-4,4,5,5-四甲基-1,3,2-二氧雜硼雜環戊烷之縮寫;11.0 mL,64.8 mmol)。滴加結束後升溫至常溫,攪拌30分鐘。加入氯化銨(60 g)之水(400 mL)溶液使反應停止,將有機層進行分液,並用飽和鹽水進行洗淨,其後,用硫酸鎂進行乾燥,並用蒸發器進行濃縮。將所獲得之固體藉由利用氯仿/己烷之再沈澱進行純化,而獲得化合物(2-1-c)(16.7 g、產率79%)。Synthesis of compound (2-1-c) The compound (2-1-b) (18.3 g, 60.0 mmol) in THF (450 mL) solution was cooled to -78°C, and 1.57 M n-butyllithium hexane solution (38.0 mL, 59.7 mmol) was added dropwise to it . Thereafter, while maintaining -78°C and stirring for 30 minutes, iPrOBpin (2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Abbreviation for alkane; 11.0 mL, 64.8 mmol). After the addition, the temperature was raised to normal temperature and stirred for 30 minutes. A solution of ammonium chloride (60 g) in water (400 mL) was added to stop the reaction, the organic layer was separated, washed with saturated brine, then dried with magnesium sulfate, and concentrated with an evaporator. The obtained solid was purified by reprecipitation with chloroform/hexane to obtain compound (2-1-c) (16.7 g, yield 79%).

[化31]

Figure 02_image063
[化31]
Figure 02_image063

化合物(2-2)之合成 於化合物(2-2-a)(396 mg、1.11 mmol)與化合物(2-1-c)(351 mg、1.00 mmol)之THF(10 mL)溶液中加入Pd2 dba3 (22.9 mg、0.025 mmol)、及P(t-Bu)3 ・HBF4 (14.4 mg、0.050 mmol)並進行攪拌。進而加入3 M磷酸鉀水溶液(1.0 mL、3.0 mmol),回流攪拌9小時。於反應溶液中加入THF,通過短矽膠管柱之後用蒸發器進行濃縮。將所獲得之固體利用矽膠管柱層析法(氯仿/甲苯=20/80)進行純化。進而利用分取GPC(gel permeation chromatograph,凝膠滲透層析儀)進行純化,而獲得化合物(2-2)(88 mg、產率18%)。Synthesis of compound (2-2) Pd was added to a solution of compound (2-2-a) (396 mg, 1.11 mmol) and compound (2-1-c) (351 mg, 1.00 mmol) in THF (10 mL) 2 dba 3 (22.9 mg, 0.025 mmol), and P(t-Bu) 3 ·HBF 4 (14.4 mg, 0.050 mmol) and stir. Furthermore, 3 M potassium phosphate aqueous solution (1.0 mL, 3.0 mmol) was added, and it stirred under reflux for 9 hours. Add THF to the reaction solution, pass through a short silica gel column, and concentrate with an evaporator. The obtained solid was purified by silica gel column chromatography (chloroform/toluene=20/80). Furthermore, it was purified by fractionation GPC (gel permeation chromatograph) to obtain compound (2-2) (88 mg, yield 18%).

1 H-NMR (400 MHz, CDCl3 ): δ (ppm) = 7.97-7.89 (m, 4H), 7.60-7.57 (m, 2H), 6.79-6.76 (m, 2H), 4.42 (t, 2H), 3.11 (s, 6H), 1.78 (tt, 2H), 1.49-1.42 (m, 2H), 1.38-1.33 (m, 4H), 0.91 (t, 3H). 1 H-NMR (400 MHz, CDCl 3 ): δ (ppm) = 7.97-7.89 (m, 4H), 7.60-7.57 (m, 2H), 6.79-6.76 (m, 2H), 4.42 (t, 2H) , 3.11 (s, 6H), 1.78 (tt, 2H), 1.49-1.42 (m, 2H), 1.38-1.33 (m, 4H), 0.91 (t, 3H).

[化32]

Figure 02_image065
[化32]
Figure 02_image065

實施例2:化合物(2-3)之合成 為了合成化合物(2-3),首先合成化合物(2-3-a)。繼而,使化合物(2-3-a)與上述化合物(2-1-c)進行鈴木偶合而獲得化合物(2-3)。Example 2: Synthesis of Compound (2-3) In order to synthesize compound (2-3), compound (2-3-a) is synthesized first. Then, the compound (2-3-a) and the above-mentioned compound (2-1-c) are subjected to Suzuki coupling to obtain the compound (2-3).

化合物(2-3-a)之合成 於EDC・HCl(1.61 g、8.41 mmol)與DMAP(0.098 g、0.80 mmol)之氯仿(80 mL)溶液中依序加入乙醇(1.85 g、40.1 mmol)、及4-溴-2,6-二氟苯甲酸(1.90 g、8.01 mmol)。於室溫下攪拌4小時後用水將反應溶液洗淨,繼而,用飽和鹽水進行洗淨,用硫酸鎂進行乾燥,用蒸發器進行濃縮。溶解於氯仿/己烷=1/1混合溶劑中,並通過短矽膠管柱後,用蒸發器進行濃縮,而獲得化合物(2-3-a)(1.32 g、產率62%)。Synthesis of compound (2-3-a) To the chloroform (80 mL) solution of EDC·HCl (1.61 g, 8.41 mmol) and DMAP (0.098 g, 0.80 mmol), add ethanol (1.85 g, 40.1 mmol), and 4-bromo-2,6-di in order. Fluorobenzoic acid (1.90 g, 8.01 mmol). After stirring at room temperature for 4 hours, the reaction solution was washed with water, and then washed with saturated brine, dried with magnesium sulfate, and concentrated with an evaporator. It was dissolved in a mixed solvent of chloroform/hexane=1/1, passed through a short silica gel column, and concentrated with an evaporator to obtain compound (2-3-a) (1.32 g, yield 62%).

[化33]

Figure 02_image067
[化33]
Figure 02_image067

化合物(2-3)之合成 於化合物(2-3-a)(292 mg、1.10 mmol)與化合物(2-1-c)(351 mg、1.00 mmol)之THF(10 mL)溶液中加入Pd2 (dba)3 (22.7 mg、0.0248 mmol)、及P(t-Bu)3 ・HBF4 (15.2 mg、0.0524 mmol)並進行攪拌。進而加入3 M磷酸鉀水溶液(1.0 mL、3.0 mmol),以60℃加熱攪拌4.5小時。於反應溶液中加入甲醇(20 mL),濾取出所析出之固體,利用以氯仿為展開溶劑之矽膠管柱層析法進行純化,而獲得化合物(2-3)(161 mg、產率39%)。Synthesis of compound (2-3) Pd was added to a solution of compound (2-3-a) (292 mg, 1.10 mmol) and compound (2-1-c) (351 mg, 1.00 mmol) in THF (10 mL) 2 (dba) 3 (22.7 mg, 0.0248 mmol), and P(t-Bu) 3 ·HBF 4 (15.2 mg, 0.0524 mmol) and stir. Furthermore, 3 M potassium phosphate aqueous solution (1.0 mL, 3.0 mmol) was added, and it heated and stirred at 60 degreeC for 4.5 hours. Methanol (20 mL) was added to the reaction solution, the precipitated solid was filtered out, and purified by silica gel column chromatography using chloroform as the developing solvent to obtain compound (2-3) (161 mg, yield 39%) ).

1 H-NMR (400 MHz, CDCl3 ): δ (ppm) = 7.95-7.89 (m, 4H), 7.69-7.66 (m, 2H), 7.26-7.22 (m, 2H), 6.79-6.75 (m, 2H), 4.45 (q, 2H), 3.11 (s, 6H), 1.42 (t, 3H). 1 H-NMR (400 MHz, CDCl 3 ): δ (ppm) = 7.95-7.89 (m, 4H), 7.69-7.66 (m, 2H), 7.26-7.22 (m, 2H), 6.79-6.75 (m, 2H), 4.45 (q, 2H), 3.11 (s, 6H), 1.42 (t, 3H).

[化34]

Figure 02_image069
[化34]
Figure 02_image069

實施例3:化合物(2-4)之合成 為了合成化合物(2-4),首先合成化合物(2-4-a)。繼而,使化合物(2-4-a)與上述化合物(2-1-c)進行鈴木偶合而獲得化合物(2-4)。Example 3: Synthesis of Compound (2-4) In order to synthesize compound (2-4), compound (2-4-a) is synthesized first. Then, the compound (2-4-a) and the above-mentioned compound (2-1-c) are subjected to Suzuki coupling to obtain the compound (2-4).

化合物(2-4-a)之合成 於EDC・HCl(1.61 g、8.41 mmol)與DMAP(0.098 g、0.80 mmol)之氯仿(80 mL)溶液中依序加入乙醇(1.84 g、40.0 mmol)、及4-溴-2-氟苯甲酸(1.75 g、8.00 mmol)。於室溫下攪拌3.5小時後用水將反應溶液洗淨,繼而,用飽和鹽水進行洗淨。用硫酸鎂進行乾燥,用蒸發器進行濃縮,而獲得化合物(2-4-a)(1.60 g、產率81%)。Synthesis of compound (2-4-a) Add ethanol (1.84 g, 40.0 mmol) and 4-bromo-2-fluorobenzoic acid to a solution of EDC・HCl (1.61 g, 8.41 mmol) and DMAP (0.098 g, 0.80 mmol) in chloroform (80 mL). (1.75 g, 8.00 mmol). After stirring at room temperature for 3.5 hours, the reaction solution was washed with water, and then washed with saturated brine. It dried with magnesium sulfate and concentrated with an evaporator to obtain compound (2-4-a) (1.60 g, yield 81%).

[化35]

Figure 02_image071
[化35]
Figure 02_image071

化合物(2-4)之合成 於化合物(2-4-a)(552 mg、2.23 mmol)與化合物(2-1-c)(704 mg、2.01 mmol)之THF(10 mL)溶液中加入Pd2 (dba)3 (46.1 mg、0.0503 mmol)、及P(t-Bu)3 ・HBF4 (29.0 mg、0.100 mmol)並進行攪拌。進而加入3 M磷酸鉀水溶液(2.0 mL、6.0 mmol),以60℃加熱攪拌3.5小時。於反應溶液中加入水(20 mL),濾取出所析出之固體,利用以氯仿為展開溶劑之矽膠管柱層析法進行純化,而獲得化合物(2-4)(480 mg、產率61%)。Synthesis of compound (2-4) Pd was added to a solution of compound (2-4-a) (552 mg, 2.23 mmol) and compound (2-1-c) (704 mg, 2.01 mmol) in THF (10 mL) 2 (dba) 3 (46.1 mg, 0.0503 mmol), and P(t-Bu) 3 ·HBF 4 (29.0 mg, 0.100 mmol) and stir. Furthermore, 3 M potassium phosphate aqueous solution (2.0 mL, 6.0 mmol) was added, and it heated and stirred at 60 degreeC for 3.5 hours. Water (20 mL) was added to the reaction solution, the precipitated solid was filtered out, and purified by silica gel column chromatography using chloroform as the developing solvent to obtain compound (2-4) (480 mg, yield 61%) ).

1 H-NMR (400 MHz, CDCl3 ): δ (ppm) = 8.02 (dd, 1H), 7.95-7.89 (m, 4H), 7.74-7.70 (m, 2H), 7.50 (dd, 1H), 7.43 (dd, 1H), 6.80-6.76 (m, 2H), 4.43 (q, 2H), 3.11 (s, 6H), 1.43 (t, 3H). 1 H-NMR (400 MHz, CDCl 3 ): δ (ppm) = 8.02 (dd, 1H), 7.95-7.89 (m, 4H), 7.74-7.70 (m, 2H), 7.50 (dd, 1H), 7.43 (dd, 1H), 6.80-6.76 (m, 2H), 4.43 (q, 2H), 3.11 (s, 6H), 1.43 (t, 3H).

[化36]

Figure 02_image073
[化36]
Figure 02_image073

實施例4:化合物(2-5)之合成 為了合成化合物(2-5),首先經由化合物(2-5-a)合成化合物(2-5-b)。繼而,使化合物(2-5-b)與4-溴苯甲酸乙酯進行鈴木偶合而獲得化合物(2-5)。Example 4: Synthesis of compound (2-5) To synthesize compound (2-5), firstly, compound (2-5-b) is synthesized via compound (2-5-a). Then, the compound (2-5-b) and ethyl 4-bromobenzoate were subjected to Suzuki coupling to obtain the compound (2-5).

化合物(2-5-a)之合成 將4-溴-2-氟苯胺(14.3 g、75.0 mmol)、35%鹽酸(22.0 mL,249 mmol)、及水(200 mL)加以混合並冷卻至0℃至5℃,向其中滴加亞硝酸鈉(7.76 g、112 mmol)之水(26 mL)溶液。其後,一面維持0℃至5℃一面攪拌30分鐘,並進而添加醯胺硫酸(4.36 g,45.0 mmol)而製備重氮液。另一方面,將二甲基苯胺(13.6 g、113 mmol)、乙酸鈉(24.6 g,300 mmol)、甲醇(200 mL)、及水(100 mL)加以混合並冷卻至0℃至5℃,滴加剛才所製備之重氮液總量。滴加結束後升溫至常溫,過濾分離出所析出之固體而獲得化合物(2-5-a)(15.8 g、產率66%)。Synthesis of compound (2-5-a) 4-Bromo-2-fluoroaniline (14.3 g, 75.0 mmol), 35% hydrochloric acid (22.0 mL, 249 mmol), and water (200 mL) were mixed and cooled to 0°C to 5°C, and sub- A solution of sodium nitrate (7.76 g, 112 mmol) in water (26 mL). Thereafter, while maintaining 0°C to 5°C, stirring for 30 minutes, and further adding amidosulfuric acid (4.36 g, 45.0 mmol) to prepare a diazonium liquid. On the other hand, dimethylaniline (13.6 g, 113 mmol), sodium acetate (24.6 g, 300 mmol), methanol (200 mL), and water (100 mL) were mixed and cooled to 0°C to 5°C, Add dropwise the total amount of diazonium liquid just prepared. After the dropwise addition, the temperature was raised to normal temperature, and the precipitated solid was separated by filtration to obtain compound (2-5-a) (15.8 g, yield 66%).

[化37]

Figure 02_image075
[化37]
Figure 02_image075

化合物(2-5-b)之合成 於化合物(2-5-a)(3.23 g、10.0 mmol)、B2 pin2 (雙(頻那醇酯)二硼烷;2.79 g、11.0 mmol)與乙酸鉀(2.99 g、30.4 mmol)之1,4-二㗁烷(60 mL)溶液中加入PdCl2 dppf(249 mg、0.305 mmol),以80℃加熱攪拌7小時。用甲苯/水將反應溶液進行分液,用水將有機層進行洗淨,繼而,用飽和鹽水進行洗淨之後,用硫酸鎂進行乾燥,並用蒸發器進行濃縮。將所獲得之固體藉由利用氯仿/己烷之再沈澱進行純化,而獲得化合物(2-5-b)(2.53 g、產率69%)。The synthesis of compound (2-5-b) is based on compound (2-5-a) (3.23 g, 10.0 mmol), B 2 pin 2 (bis(pinacol ester) diborane; 2.79 g, 11.0 mmol) and PdCl 2 dppf (249 mg, 0.305 mmol) was added to a solution of potassium acetate (2.99 g, 30.4 mmol) in 1,4-dioxane (60 mL), and the mixture was heated and stirred at 80° C. for 7 hours. The reaction solution was separated with toluene/water, the organic layer was washed with water, and then washed with saturated brine, dried with magnesium sulfate, and concentrated with an evaporator. The obtained solid was purified by reprecipitation with chloroform/hexane to obtain compound (2-5-b) (2.53 g, yield 69%).

[化38]

Figure 02_image077
[化38]
Figure 02_image077

化合物(2-5)之合成 於4-溴苯甲酸乙酯(0.763 g、3.33 mmol)與化合物(2-5-b)(1.11 g、3.00 mmol)之THF(30 mL)溶液中加入Pd2 (dba)3 (69.8 mg、0.0762 mmol)、及P(t-Bu)3 ・HBF4 (45.0 mg、0.155 mmol)並進行攪拌。進而加入3 M磷酸鉀水溶液(4.0 mL、12.0 mmol),並以60℃加熱攪拌4小時。於反應溶液中加入甲醇(20 mL),濾取出所析出之固體,利用以氯仿為展開溶劑之矽膠管柱層析法進行純化,而獲得化合物(2-5)(904 mg、產率77%)。 Synthesis of compound (2-5) Pd 2 was added to a solution of ethyl 4-bromobenzoate (0.763 g, 3.33 mmol) and compound (2-5-b) (1.11 g, 3.00 mmol) in THF (30 mL) (dba) 3 (69.8 mg, 0.0762 mmol), and P(t-Bu) 3 ·HBF 4 (45.0 mg, 0.155 mmol) and stir. Furthermore, 3 M potassium phosphate aqueous solution (4.0 mL, 12.0 mmol) was added, and it heated and stirred at 60 degreeC for 4 hours. Methanol (20 mL) was added to the reaction solution, the precipitated solid was filtered out, and purified by silica gel column chromatography using chloroform as the developing solvent to obtain compound (2-5) (904 mg, yield 77%) ).

1 H-NMR (400 MHz, CDCl3 ): δ (ppm) = 8.15-8.12 (m, 2H), 7.95-7.91 (m, 2H), 7.84 (d, 1H), 7.72-7.68 (m, 2H), 7.52-7.45 (m, 2H), 6.79-6.75 (m, 2H), 4.42 (q, 2H), 3.12 (s, 6H), 1.43 (t, 3H). 1 H-NMR (400 MHz, CDCl 3 ): δ (ppm) = 8.15-8.12 (m, 2H), 7.95-7.91 (m, 2H), 7.84 (d, 1H), 7.72-7.68 (m, 2H) , 7.52-7.45 (m, 2H), 6.79-6.75 (m, 2H), 4.42 (q, 2H), 3.12 (s, 6H), 1.43 (t, 3H).

[化39]

Figure 02_image079
[化39]
Figure 02_image079

實施例5:化合物(2-7)之合成 為了合成化合物(2-7),首先經由上述化合物(2-5-a)合成化合物(2-6-a)。繼而,使化合物(2-6-a)與4-正辛氧基苯甲酸進行脫水縮合而獲得化合物(2-7)。Example 5: Synthesis of Compound (2-7) In order to synthesize the compound (2-7), first, the compound (2-6-a) is synthesized via the above-mentioned compound (2-5-a). Then, the compound (2-6-a) and 4-n-octyloxybenzoic acid are dehydrated and condensed to obtain the compound (2-7).

化合物(2-6-a)之合成 於化合物(2-5-a)(1.61 g、5.00 mmol)與氫氧化鉀(0.83 g、15 mmol)之1,4-二㗁烷(7.5 mL)、及水(7.5 mL)之混合溶液中加入Pd2 (dba)3 (91.6 mg、0.100 mmol)、及t-BuXPhos(170 mg、0.401 mmol),以100℃加熱攪拌1.5小時。於反應溶液中加入乙酸(1 mL)使反應停止,用乙酸乙酯/水進行分液,用水將有機層洗淨,繼而,用飽和鹽水進行洗淨,其後,用硫酸鎂進行乾燥,並用蒸發器進行濃縮。將所獲得之固體利用矽膠管柱層析法(乙酸乙酯/氯仿=10/90)進行純化,而獲得化合物(2-6-a)。(1.02 g、產率79%)。The synthesis of compound (2-6-a) is based on compound (2-5-a) (1.61 g, 5.00 mmol) and potassium hydroxide (0.83 g, 15 mmol) in 1,4-dioxane (7.5 mL), Pd 2 (dba) 3 (91.6 mg, 0.100 mmol) and t-BuXPhos (170 mg, 0.401 mmol) were added to the mixed solution of water (7.5 mL) and heated at 100° C. and stirred for 1.5 hours. Acetic acid (1 mL) was added to the reaction solution to stop the reaction, and the solution was separated with ethyl acetate/water. The organic layer was washed with water, and then washed with saturated brine, and then dried with magnesium sulfate. The evaporator performs concentration. The obtained solid was purified by silica gel column chromatography (ethyl acetate/chloroform=10/90) to obtain compound (2-6-a). (1.02 g, yield 79%).

[化40]

Figure 02_image081
[化40]
Figure 02_image081

化合物(2-7)之合成 於EDC・HCl(207 mg、1.05 mmol)與DMAP(13.4 mg、0.10 mmol)之氯仿(10 mL)溶液中依序加入化合物(2-6-a)(0.260 g、1.00 mmol)、及4-正辛氧基苯甲酸(0.251 g、1.00 mmol)。於室溫下攪拌6小時後用水將反應溶液洗淨,繼而,用飽和鹽水進行洗淨,用硫酸鎂進行乾燥,並用蒸發器進行濃縮。將所獲得之固體利用再結晶(氯仿/甲醇)進行純化,而獲得化合物(2-7)(379 mg、產率77%)。Synthesis of compound (2-7) To the chloroform (10 mL) solution of EDC·HCl (207 mg, 1.05 mmol) and DMAP (13.4 mg, 0.10 mmol), compound (2-6-a) (0.260 g, 1.00 mmol), and 4- N-octyloxybenzoic acid (0.251 g, 1.00 mmol). After stirring at room temperature for 6 hours, the reaction solution was washed with water, and then washed with saturated brine, dried with magnesium sulfate, and concentrated with an evaporator. The obtained solid was purified by recrystallization (chloroform/methanol) to obtain compound (2-7) (379 mg, yield 77%).

1 H-NMR (400 MHz, CDCl3 ): δ (ppm) = 8.15-8.11 (m, 2H), 7.92-7.88 (m, 2H), 7.81 (dd, 1H), 7.16 (dd, 2H), 7.07-7.04 (m, 2H), 6.99-6.95 (m, 2H), 6.76-6.72 (m, 2H), 4.04 (t, 2H), 3.09 (s, 6H), 1.82 (tt, 2H), 1.51-1.43 (m, 2H), 1.40-1.24 (m, 8H), 0.89 (t, 3H). 1 H-NMR (400 MHz, CDCl 3 ): δ (ppm) = 8.15-8.11 (m, 2H), 7.92-7.88 (m, 2H), 7.81 (dd, 1H), 7.16 (dd, 2H), 7.07 -7.04 (m, 2H), 6.99-6.95 (m, 2H), 6.76-6.72 (m, 2H), 4.04 (t, 2H), 3.09 (s, 6H), 1.82 (tt, 2H), 1.51-1.43 (m, 2H), 1.40-1.24 (m, 8H), 0.89 (t, 3H).

[化41]

Figure 02_image083
[化41]
Figure 02_image083

實施例6:化合物(2-101)之合成 為了合成化合物(2-101),首先合成化合物(2-101-a)。 繼而,使化合物(2-101-a)與上述化合物(2-5-b)進行鈴木偶合而獲得化合物(2-101-b)。繼而,藉由酯交換反應而獲得化合物(2-101)。Example 6: Synthesis of Compound (2-101) In order to synthesize compound (2-101), compound (2-101-a) is synthesized first. Then, the compound (2-101-a) and the above-mentioned compound (2-5-b) are subjected to Suzuki coupling to obtain the compound (2-101-b). Then, the compound (2-101) is obtained by the transesterification reaction.

化合物(2-101-a)之合成 於溴化銅(II)(6.48 g、29.0 mmol)之乙腈(200 mL)溶液中依序加入亞硝酸異丁酯(4.40 mL、37 mmol)、及2-胺基苯并噻唑-6-羧酸乙酯(5.56 g、25.0 mmol)。以65℃攪拌1.5小時後使反應溶液冷卻至室溫,其後,注入0.4 M鹽酸(200 mL)使反應停止。用氯仿/水進行分液後用水將有機層洗淨,繼而,用飽和鹽水進行洗淨,用硫酸鎂進行乾燥,並用蒸發器進行濃縮,藉此獲得化合物(2-101-a)(6.56 g、產率92%)。Synthesis of compound (2-101-a) To a solution of copper(II) bromide (6.48 g, 29.0 mmol) in acetonitrile (200 mL), add isobutyl nitrite (4.40 mL, 37 mmol) and 2-aminobenzothiazole-6-carboxyl in order Ethyl ester (5.56 g, 25.0 mmol). After stirring at 65°C for 1.5 hours, the reaction solution was cooled to room temperature, and then 0.4 M hydrochloric acid (200 mL) was injected to stop the reaction. After separation with chloroform/water, the organic layer was washed with water, and then washed with saturated brine, dried with magnesium sulfate, and concentrated with an evaporator to obtain compound (2-101-a) (6.56 g) , Yield 92%).

[化42]

Figure 02_image085
[化42]
Figure 02_image085

化合物(2-101-b)之合成 於化合物(2-101-a)(0.631 g、2.21 mmol)與化合物(2-5-b)(0.739 g、2.00 mmol)之THF(20 mL)溶液中加入Pd2 (dba)3 (0.0464 g、0.0507 mmol)、及P(t-Bu)3 ・HBF4 (0.0290 g、0.100 mmol)並進行攪拌。進而加入3 M磷酸鉀水溶液(2.0 mL、6.0 mmol),以60℃加熱攪拌12小時。於反應溶液中加入甲醇,濾取出所析出之固體,而獲得化合物(2-101-b)(0.782 g、產率87%)。The synthesis of compound (2-101-b) was in the solution of compound (2-101-a) (0.631 g, 2.21 mmol) and compound (2-5-b) (0.739 g, 2.00 mmol) in THF (20 mL) Pd 2 (dba) 3 (0.0464 g, 0.0507 mmol), and P(t-Bu) 3 ·HBF 4 (0.0290 g, 0.100 mmol) were added and stirred. Furthermore, 3 M potassium phosphate aqueous solution (2.0 mL, 6.0 mmol) was added, and it heated and stirred at 60 degreeC for 12 hours. Methanol was added to the reaction solution, and the precipitated solid was filtered out to obtain compound (2-101-b) (0.782 g, yield 87%).

[化43]

Figure 02_image087
[化43]
Figure 02_image087

化合物(2-101)之合成 使化合物(2-101-b)(0.450 g、1.00 mmol)、TiO(acac)2 (雙(2,4-戊二酮基)鈦(IV)氧化物之縮寫;0.132 g、0.504 mmol)與正己醇(0.512 g、5.01 mmol)之對二甲苯(15 mL)溶液加熱回流4小時。於反應溶液中加入甲醇,濾取出所析出之固體,利用以氯仿為展開溶劑之矽膠管柱層析法進行純化,而獲得化合物(2-101)(0.366 g、產率72%)。The synthesis of compound (2-101) makes compound (2-101-b) (0.450 g, 1.00 mmol), TiO(acac) 2 (abbreviation for bis(2,4-pentanedionyl) titanium(IV) oxide) A solution of 0.132 g, 0.504 mmol) and n-hexanol (0.512 g, 5.01 mmol) in p-xylene (15 mL) was heated to reflux for 4 hours. Methanol was added to the reaction solution, the precipitated solid was filtered out, and purified by silica gel column chromatography using chloroform as the developing solvent to obtain compound (2-101) (0.366 g, yield 72%).

1 H-NMR (400 MHz, CDCl3 ): δ (ppm) = 8.65 (d, 1H), 8.19 (dd, 1H), 8.11 (d, 1H), 8.02 (dd, 1H), 7.97-7.91 (m, 3H), 7.88 (dd, 1H), 6.79-6.75 (m, 2H), 4.38 (t, 2H), 3.13 (s, 6H), 1.82 (tt, 2H), 1.52-1.45 (m, 2H), 1.40-1.34 (m, 4H), 0.92 (t, 3H). 1 H-NMR (400 MHz, CDCl 3 ): δ (ppm) = 8.65 (d, 1H), 8.19 (dd, 1H), 8.11 (d, 1H), 8.02 (dd, 1H), 7.97-7.91 (m , 3H), 7.88 (dd, 1H), 6.79-6.75 (m, 2H), 4.38 (t, 2H), 3.13 (s, 6H), 1.82 (tt, 2H), 1.52-1.45 (m, 2H), 1.40-1.34 (m, 4H), 0.92 (t, 3H).

[化44]

Figure 02_image089
[化44]
Figure 02_image089

實施例7:化合物(2-76)之合成 使2-溴-5-正丁基噻吩并噻唑與上述化合物(2-5-b)進行鈴木偶合而獲得化合物(2-76)。Example 7: Synthesis of Compound (2-76) Suzuki coupling of 2-bromo-5-n-butylthienothiazole and the above-mentioned compound (2-5-b) gave compound (2-76).

化合物(2-76)之合成 於2-溴-5-正丁基噻吩并噻唑(0.304 g、1.10 mmol)與化合物(2-5-b)(0.369 g、1.00 mmol)之THF(10 mL)溶液中加入Pd2 (dba)3 (0.0367 mg、0.0400 mmol)、及P(t-Bu)3 ・HBF4 (0.0232 mg、0.0800 mmol)並進行攪拌。進而加入3 M磷酸鉀水溶液(2.0 mL、6.0 mmol),並加熱攪拌16小時。於反應溶液中加入甲醇,濾取出所析出之固體,利用矽膠管柱層析法(氯仿/甲苯=10/90)進行純化,而獲得化合物(2-76)(0.127 g、產率29%)。Compound (2-76) was synthesized in 2-bromo-5-n-butylthienothiazole (0.304 g, 1.10 mmol) and compound (2-5-b) (0.369 g, 1.00 mmol) in THF (10 mL) Pd 2 (dba) 3 (0.0367 mg, 0.0400 mmol), and P(t-Bu) 3 ·HBF 4 (0.0232 mg, 0.0800 mmol) were added to the solution and stirred. Furthermore, 3 M potassium phosphate aqueous solution (2.0 mL, 6.0 mmol) was added, and it heat-stirred for 16 hours. Methanol was added to the reaction solution, the precipitated solid was filtered out, and purified by silica gel column chromatography (chloroform/toluene = 10/90) to obtain compound (2-76) (0.127 g, yield 29%) .

1 H-NMR (400 MHz, CDCl3 ): δ (ppm) = 9.95-7.91 (m, 2H), 7.87-7.81 (m, 2H), 7.77 (dd, 1H), 6.95 (s, 1H), 6.78-6.74 (m, 2H), 3.12 (s, 6H), 2.92 (t, 2H), 1.74 (tt, 2H), 1.44 (tq, 2H), 0.97 (t, 3H). 1 H-NMR (400 MHz, CDCl 3 ): δ (ppm) = 9.95-7.91 (m, 2H), 7.87-7.81 (m, 2H), 7.77 (dd, 1H), 6.95 (s, 1H), 6.78 -6.74 (m, 2H), 3.12 (s, 6H), 2.92 (t, 2H), 1.74 (tt, 2H), 1.44 (tq, 2H), 0.97 (t, 3H).

[化45]

Figure 02_image091
[化45]
Figure 02_image091

實施例8:化合物(2-102)之合成 為了合成化合物(2-102),首先經由上述化合物(2-101-a)、及化合物(2-102-a)合成化合物(2-102-b)。繼而,經由化合物(2-102-c)合成化合物(2-102-d)。使化合物(2-102-b)與化合物(2-102-d)進行鈴木偶合而獲得化合物(2-102)。Example 8: Synthesis of Compound (2-102) In order to synthesize the compound (2-102), first, the compound (2-102-b) is synthesized via the above-mentioned compound (2-101-a) and the compound (2-102-a). Next, compound (2-102-d) was synthesized via compound (2-102-c). Compound (2-102-b) and compound (2-102-d) are subjected to Suzuki coupling to obtain compound (2-102).

化合物(2-102-a)之合成 將化合物(2-101-a)(10.3 g、36.0 mmol)、氫氧化鋰一水合物(7.55 g,180 mmol)、及THF(360 mL)加以混合並冷卻至0℃至5℃,向其中加入水(120 mL)並升溫至常溫。於常溫下攪拌3天之後注入1 M鹽酸(200 mL)使反應停止。用乙酸乙酯/水進行分液後用水將有機層洗淨,繼而,用飽和鹽水進行洗淨,用硫酸鎂進行乾燥,並用蒸發器進行濃縮,藉此獲得化合物(2-102-a)(9.02 g、產率97%)。Synthesis of compound (2-102-a) Compound (2-101-a) (10.3 g, 36.0 mmol), lithium hydroxide monohydrate (7.55 g, 180 mmol), and THF (360 mL) were mixed and cooled to 0°C to 5°C, and added Add water (120 mL) and increase the temperature to room temperature. After stirring at room temperature for 3 days, 1 M hydrochloric acid (200 mL) was injected to stop the reaction. After separation with ethyl acetate/water, the organic layer was washed with water, and then washed with saturated brine, dried with magnesium sulfate, and concentrated with an evaporator to obtain compound (2-102-a) ( 9.02 g, yield 97%).

[化46]

Figure 02_image093
[化46]
Figure 02_image093

化合物(2-102-b)之合成 於EDC・HCl(3.02 g、15.8 mmol)與DMAP(184 mg、1.50 mmol)之氯仿(150 mL)溶液中依序加入正己醇(1.61 g、15.7 mmol)、及化合物(2-102-a)(3.87 g、15.0 mmol)。於室溫下攪拌7.5小時後用水將反應溶液洗淨,繼而,用飽和鹽水進行洗淨,用硫酸鎂進行乾燥並通過短矽膠管柱後,用蒸發器進行濃縮,藉此獲得化合物(2-102-b)(4.44 g、產率87%)。Synthesis of compound (2-102-b) Add n-hexanol (1.61 g, 15.7 mmol) and compound (2-102-a) to the chloroform (150 mL) solution of EDC·HCl (3.02 g, 15.8 mmol) and DMAP (184 mg, 1.50 mmol) in sequence (3.87 g, 15.0 mmol). After stirring at room temperature for 7.5 hours, the reaction solution was washed with water, followed by washing with saturated brine, drying with magnesium sulfate and passing through a short silica gel column, and then concentrating with an evaporator to obtain compound (2- 102-b) (4.44 g, yield 87%).

[化47]

Figure 02_image095
[化47]
Figure 02_image095

化合物(2-102-c)之合成 將4-溴-3-氟苯胺(1.90 g、10.0 mmol)、35%鹽酸(3.0 mL、34 mmol)、及水(25 mL)加以混合並冷卻至0℃至5℃,向其中滴加亞硝酸鈉(0.69 mg、10.0 mmol)之水(2.5 mL)溶液而製備重氮液。另一方面,將二甲基苯胺(1.33 g、11.0 mmol)、乙酸鈉(3.28 g、40.0 mmol)、甲醇(25.0 mL)、及水(12.5 mL)加以混合並冷卻至0℃至5℃,滴加剛才所製備之重氮液總量。滴加結束後升溫至常溫,過濾分離出所析出之固體而獲得化合物(2-102-c)(2.59 g、產率80%)。Synthesis of compound (2-102-c) 4-Bromo-3-fluoroaniline (1.90 g, 10.0 mmol), 35% hydrochloric acid (3.0 mL, 34 mmol), and water (25 mL) were mixed and cooled to 0°C to 5°C, and added dropwise to it. A solution of sodium nitrate (0.69 mg, 10.0 mmol) in water (2.5 mL) was used to prepare a diazonium solution. On the other hand, dimethylaniline (1.33 g, 11.0 mmol), sodium acetate (3.28 g, 40.0 mmol), methanol (25.0 mL), and water (12.5 mL) were mixed and cooled to 0°C to 5°C, Add dropwise the total amount of diazonium liquid just prepared. After the dropping, the temperature was raised to normal temperature, and the precipitated solid was separated by filtration to obtain compound (2-102-c) (2.59 g, yield 80%).

[化48]

Figure 02_image097
[化48]
Figure 02_image097

化合物(2-102-d)之合成 於化合物(2-102-c)(2.26 g、7.00 mmol)、B2 pin2 (正式名稱為雙(頻那醇酯)二硼烷;1.96 g、7.70 mmol)與乙酸鉀(2.06 g、21.0 mmol)之1,4-二㗁烷(35 mL)溶液中加入PdCl2 dppf(0.286 g、0.351 mmol),並以80℃加熱攪拌15小時。用甲苯/水將反應溶液進行分液,用水將有機層洗淨,繼而,用飽和鹽水進行洗淨後用硫酸鎂進行乾燥,並用蒸發器進行濃縮。將所獲得之固體藉由利用氯仿/己烷之再沈澱進行純化,而獲得化合物(2-102-d)(1.74 g、產率67%)。The synthesis of compound (2-102-d) is in compound (2-102-c) (2.26 g, 7.00 mmol), B 2 pin 2 (official name is bis(pinacol ester) diborane; 1.96 g, 7.70) PdCl 2 dppf (0.286 g, 0.351 mmol) was added to a 1,4-dioxane (35 mL) solution of potassium acetate (2.06 g, 21.0 mmol) and potassium acetate (2.06 g, 21.0 mmol), followed by heating and stirring at 80°C for 15 hours. The reaction solution was separated with toluene/water, the organic layer was washed with water, and then washed with saturated brine, dried with magnesium sulfate, and concentrated with an evaporator. The obtained solid was purified by reprecipitation with chloroform/hexane to obtain compound (2-102-d) (1.74 g, yield 67%).

[化49]

Figure 02_image099
[化49]
Figure 02_image099

化合物(2-102)之合成 於化合物(2-102-b)(0.378 g、1.10 mmol)與化合物(2-102-d)(0.369 g、1.00 mmol)之1,4-二㗁烷(10 mL)溶液中加入Pd2 (dba)3 (0.0231 g、0.0252 mmol)、及P(t-Bu)3 ・HBF4 (0.0145 g、0.0500 mmol)並進行攪拌。進而加入3 M磷酸鉀水溶液(1.0 mL、3.0 mmol),並以100℃加熱攪拌3小時。於反應溶液中加入甲醇,濾取出所析出之固體,利用以氯仿為展開溶劑之矽膠管柱層析法進行純化,進而藉由利用氯仿/甲醇之再沈澱進行純化,而獲得化合物(2-102)(0.356 g、產率71%)。Compound (2-102) was synthesized in compound (2-102-b) (0.378 g, 1.10 mmol) and compound (2-102-d) (0.369 g, 1.00 mmol) in 1,4-dioxane (10 (mL) Pd 2 (dba) 3 (0.0231 g, 0.0252 mmol) and P(t-Bu) 3 ·HBF 4 (0.0145 g, 0.0500 mmol) were added to the solution and stirred. Furthermore, 3 M potassium phosphate aqueous solution (1.0 mL, 3.0 mmol) was added, and it heat-stirred at 100 degreeC for 3 hours. Methanol was added to the reaction solution, the precipitated solid was filtered out, purified by silica gel column chromatography using chloroform as the developing solvent, and then purified by reprecipitation with chloroform/methanol to obtain compound (2-102 ) (0.356 g, yield 71%).

1 H-NMR (400 MHz, CDCl3 ): δ (ppm) = 8.68 (d, 1H), 8.57 (dd, 1H), 8.20 (dd, 1H), 8.14 (d, 1H), 7.95-7.91 (m, 2H), 7.83 (dd, 1H), 7.72 (dd, 1H), 6.80-6.76 (m, 2H), 4.38 (t, 2H), 3.14 (s, 6H), 1.82 (tt, 2H), 1.52-1.45 (m, 2H), 1.40-1.34 (m, 4H), 0.92 (t, 3H). 1 H-NMR (400 MHz, CDCl 3 ): δ (ppm) = 8.68 (d, 1H), 8.57 (dd, 1H), 8.20 (dd, 1H), 8.14 (d, 1H), 7.95-7.91 (m , 2H), 7.83 (dd, 1H), 7.72 (dd, 1H), 6.80-6.76 (m, 2H), 4.38 (t, 2H), 3.14 (s, 6H), 1.82 (tt, 2H), 1.52- 1.45 (m, 2H), 1.40-1.34 (m, 4H), 0.92 (t, 3H).

[化50]

Figure 02_image101
[化50]
Figure 02_image101

實施例9:化合物(2-77)之合成 使2-溴-5-正丁基噻吩并噻唑與上述化合物(2-102-d)進行鈴木偶合而獲得化合物(2-77)。Example 9: Synthesis of Compound (2-77) Suzuki coupling of 2-bromo-5-n-butylthienothiazole and the above-mentioned compound (2-102-d) gave compound (2-77).

化合物(2-77)之合成 於2-溴-5-正丁基噻吩并噻唑(0.307 g、1.11 mmol)與化合物(2-102-d)(0.370 g、1.00 mmol)之1,4-二㗁烷(10 mL)溶液中加入Pd2 (dba)3 (0.023 g、0.0251 mmol)、及P(t-Bu)3 ・HBF4 (0.015 g、0.0517 mmol)並進行攪拌。進而加入3 M磷酸鉀水溶液(1.0 mL、3.0 mmol),並加熱攪拌4小時。於反應溶液中加入甲醇,濾取出所析出之固體,利用以氯仿為展開溶劑之矽膠管柱層析法進行純化,進而藉由利用氯仿/甲醇之再沈澱進行純化,而獲得化合物(2-77)(0.317 g、產率72%)。Compound (2-77) was synthesized in 1,4-bis 2-bromo-5-n-butylthienothiazole (0.307 g, 1.11 mmol) and compound (2-102-d) (0.370 g, 1.00 mmol) Pd 2 (dba) 3 (0.023 g, 0.0251 mmol), and P(t-Bu) 3 ·HBF 4 (0.015 g, 0.0517 mmol) were added to the ethane (10 mL) solution and stirred. Furthermore, 3 M potassium phosphate aqueous solution (1.0 mL, 3.0 mmol) was added, and it heated and stirred for 4 hours. Methanol was added to the reaction solution, the precipitated solid was filtered out, purified by silica gel column chromatography using chloroform as the developing solvent, and then purified by reprecipitation with chloroform/methanol to obtain compound (2-77 ) (0.317 g, yield 72%).

1 H-NMR (400 MHz, CDCl3 ): δ (ppm) = 8.42 (dd, 1H), 7.92-7.89 (m, 2H), 7.78 (dd, 1H), 7.68 (dd, 1H), 6.97 (s, 1H), 6.79-6.75 (m, 2H), 3.12 (s, 6H), 2.93 (t, 2H), 1.75 (tt, 2H), 1.45 (tq, 2H), 0.97 (t, 3H). 1 H-NMR (400 MHz, CDCl 3 ): δ (ppm) = 8.42 (dd, 1H), 7.92-7.89 (m, 2H), 7.78 (dd, 1H), 7.68 (dd, 1H), 6.97 (s , 1H), 6.79-6.75 (m, 2H), 3.12 (s, 6H), 2.93 (t, 2H), 1.75 (tt, 2H), 1.45 (tq, 2H), 0.97 (t, 3H).

[化51]

Figure 02_image103
[化51]
Figure 02_image103

比較例1:化合物(2-1)之合成 為了合成化合物(2-1),首先合成化合物(2-1-a)。繼而,使化合物(2-1-a)與上述化合物(2-1-c)進行鈴木偶合而獲得化合物(2-1)。Comparative Example 1: Synthesis of Compound (2-1) In order to synthesize compound (2-1), compound (2-1-a) is synthesized first. Then, the compound (2-1-a) and the above-mentioned compound (2-1-c) are subjected to Suzuki coupling to obtain the compound (2-1).

化合物(2-1-a)之合成 於EDC・HCl(1.36 g、7.10 mmol)與DMAP(0.083 g、0.68 mmol)之二氯甲烷(60 mL)溶液中依序加入正己醇(0.90 mL、7.2 mmol)、及4-溴苯甲酸(1.36 g、6.76 mmol)。於室溫下攪拌6小時後用水將反應溶液洗淨,繼而,用飽和鹽水進行洗淨,用硫酸鎂進行乾燥,並用蒸發器進行濃縮,藉此獲得化合物(2-1-a)(1.70 g、產率88%)。Synthesis of compound (2-1-a) To a solution of EDC·HCl (1.36 g, 7.10 mmol) and DMAP (0.083 g, 0.68 mmol) in dichloromethane (60 mL) was added n-hexanol (0.90 mL, 7.2 mmol), and 4-bromobenzoic acid ( 1.36 g, 6.76 mmol). After stirring at room temperature for 6 hours, the reaction solution was washed with water, followed by washing with saturated brine, drying with magnesium sulfate, and concentrating with an evaporator to obtain compound (2-1-a) (1.70 g) , Yield 88%).

[化52]

Figure 02_image105
[化52]
Figure 02_image105

化合物(2-1)之合成 於化合物(2-1-a)(285 mg、1.00 mmol)、化合物(2-1-c)(457 mg、1.30 mmol)、及乙酸鉀(650 mg、6.63 mmol)之二乙二醇二甲醚(13 mL)與水(2 mL)之混合溶液中加入PdCl2 dppf(41.0 mg、0.0502 mmol),並以140℃加熱攪拌4小時。於反應溶液中加入THF並使之通過短矽膠管柱後,用蒸發器進行濃縮。將所獲得之固體用甲醇/水進行洗淨後,利用矽膠管柱層析法(氯仿/甲苯=20/80)進行純化,而獲得化合物(2-1)(238 mg、產率55%)。Compound (2-1) was synthesized in compound (2-1-a) (285 mg, 1.00 mmol), compound (2-1-c) (457 mg, 1.30 mmol), and potassium acetate (650 mg, 6.63 mmol) PdCl 2 dppf (41.0 mg, 0.0502 mmol) was added to the mixed solution of diethylene glycol dimethyl ether (13 mL) and water (2 mL), and heated and stirred at 140°C for 4 hours. After adding THF to the reaction solution and passing it through a short silica gel column, it is concentrated with an evaporator. After washing the obtained solid with methanol/water, it was purified by silica gel column chromatography (chloroform/toluene=20/80) to obtain compound (2-1) (238 mg, yield 55%) .

1 H-NMR (400 MHz, CDCl3 ): δ (ppm) = 8.14-8.11 (m, 2H), 7.95-7.89 (m, 4H), 7.76-7.71 (m, 4H), 6.80-6.76 (m, 2H), 4.35 (t, 2H), 3.11 (s, 6H), 1.79 (tt, 2H), 1.51-1.44 (m, 2H), 1.37-1.33 (m, 4H), 0.92 (t, 3H). 1 H-NMR (400 MHz, CDCl 3 ): δ (ppm) = 8.14-8.11 (m, 2H), 7.95-7.89 (m, 4H), 7.76-7.71 (m, 4H), 6.80-6.76 (m, 2H), 4.35 (t, 2H), 3.11 (s, 6H), 1.79 (tt, 2H), 1.51-1.44 (m, 2H), 1.37-1.33 (m, 4H), 0.92 (t, 3H).

[化53]

Figure 02_image107
[化53]
Figure 02_image107

<評價> 組合物之製備 將聚(甲基丙烯酸甲酯)(PMMA,Aldrich製造,Mw=約120000)10質量%甲苯水溶液1 g、實施例1中所獲得之化合物(2-2)4 mg、及光自由基起始劑(Irgacure 369)6 mg加以混合,並以80℃加熱30分鐘而製備組合物E1。<Evaluation> Preparation of the composition 1 g of poly(methyl methacrylate) (PMMA, manufactured by Aldrich, Mw=about 120,000) 10% by mass toluene aqueous solution, 4 mg of the compound (2-2) obtained in Example 1, and photo-radical start (Irgacure 369) 6 mg was mixed and heated at 80°C for 30 minutes to prepare composition E1.

使用化合物(2-3)至(2-5)、化合物(2-7)、化合物(2-101)、化合物(2-76)、化合物(2-102)、化合物(2-77)或化合物(2-1)代替化合物(2-2),除此以外,與上述相同地獲得組合物E2至E9及組合物C1。Use compound (2-3) to (2-5), compound (2-7), compound (2-101), compound (2-76), compound (2-102), compound (2-77) or compound (2-1) Except for replacing the compound (2-2), compositions E2 to E9 and composition C1 were obtained in the same manner as described above.

薄膜之形成 使用玻璃基板作為透明基材。使用旋轉塗佈機(MS-A100,轉數1000 rpm,20秒鐘)於玻璃基板上旋轉塗佈組合物E1以形成薄膜,獲得評價用之積層體。Film formation Use a glass substrate as a transparent substrate. The composition E1 was spin-coated on a glass substrate using a spin coater (MS-A100, rotation speed of 1000 rpm, 20 seconds) to form a thin film, and a laminate for evaluation was obtained.

使用組合物E2至E9、或組合物C1代替組合物E1,除此以外,與上述相同地形成薄膜,分別獲得評價用之積層體。Except for using the composition E2 to E9 or the composition C1 instead of the composition E1, a thin film was formed in the same manner as above, and a laminate for evaluation was obtained, respectively.

吸光度測定 針對上述中所獲得之評價用之積層體,使用分光光度計(Varian公司製造,CARYUV-vis-NIR Spectrophotometer 5E)於常溫(25℃)下測定UV-vis光譜,獲得極大吸收波長(λmax1 )及極大吸收波長(λmax1 )下之吸光度(abs1 )。其後,利用曝光機(大日本科研製造,MA-1300A型)於25℃下對評價用之積層體照射3000 mJ/cm2 之UV光,其後再次測定UV-vis光譜,獲得UV照射後之極大吸收波長(λmax2 )及極大吸收波長(λmax2 )下之吸光度(abs2 )。用UV照射後之吸光度(abs2 )除以UV照射前之吸光度(abs1 ),算出吸光度維持率(%)。將結果示於表1。於積層體之吸光度之維持率超過80%之情形時,視為作為偏光板良好。Absorbance measurement For the laminate for evaluation obtained in the above, the UV-vis spectrum was measured using a spectrophotometer (manufactured by Varian, CARYUV-vis-NIR Spectrophotometer 5E) at room temperature (25°C) to obtain the maximum absorption wavelength (λ) max1 ) and absorbance (abs 1 ) at the maximum absorption wavelength (λ max1 ). After that, an exposure machine (manufactured by Dainippon Scientific Research, MA-1300A) was used to irradiate the evaluation laminate with 3000 mJ/cm 2 of UV light at 25°C, and then the UV-vis spectrum was measured again to obtain the UV irradiation The maximum absorption wavelength (λ max2 ) and the absorbance (abs 2 ) at the maximum absorption wavelength (λ max2 ). Divide the absorbance after UV irradiation (abs 2 ) by the absorbance before UV irradiation (abs 1 ) to calculate the absorbance maintenance rate (%). The results are shown in Table 1. When the retention rate of the absorbance of the laminate exceeds 80%, it is regarded as good as a polarizing plate.

[表1]    化合物 UV照射前 UV照射後 吸光度維持率 (%) 吸光度 (abs1 ) λmax1 (nm) 吸先度 (abs2 ) λmax2 (nm) 實施例1 2-2 0.184 439 0.157 439 85.3 實施例2 2-3 0.204 443 0.181 443 88.7 實施例3 2-4 0.172 442 0.164 442 95.4 實施例4 2-5 0.192 460 0.179 460 93.2 實施例5 2-7 0.16 432 0.135 432 84.4 實施例6 2-101 0.458 485 0.409 484 89.3 實施例7 2-76 0.398 480 0.324 478 81.4 實施例8 2-102 0.75 481 0.888 482 91.7 實施例9 2-77 0.718 476 0.659 476 92 比較例1 2-1 0.204 436 0.16 436 78.4 [Table 1] Compound Before UV irradiation After UV irradiation Absorbance maintenance rate (%) Absorbance (abs 1 ) λ max1 (nm) First suction (abs 2 ) λmax2 (nm) Example 1 2-2 0.184 439 0.157 439 85.3 Example 2 2-3 0.204 443 0.181 443 88.7 Example 3 2-4 0.172 442 0.164 442 95.4 Example 4 2-5 0.192 460 0.179 460 93.2 Example 5 2-7 0.16 432 0.135 432 84.4 Example 6 2-101 0.458 485 0.409 484 89.3 Example 7 2-76 0.398 480 0.324 478 81.4 Example 8 2-102 0.75 481 0.888 482 91.7 Example 9 2-77 0.718 476 0.659 476 92 Comparative example 1 2-1 0.204 436 0.16 436 78.4

根據表1可知,式(1)所表示之化合物之紫外線(UV)耐久性較高。According to Table 1, it can be seen that the ultraviolet (UV) durability of the compound represented by formula (1) is relatively high.

Figure 109124436-A0101-11-0001-2
Figure 109124436-A0101-11-0001-2

Claims (9)

一種化合物,其以下述式(1)表示; R4 -R3 -Ar1 -(-R1 -Ar2 -)n -N=N-Ar3 -R2 (1) [式(1)中,Ar1 、Ar2 及Ar3 分別獨立地表示可具有取代基之1,4-伸苯基或可具有取代基之2價含硫芳香族雜環基,Ar1 及Ar2 之至少一者具有氟原子作為取代基; n表示1或2之整數; R1 表示單鍵、或選自由-OC(=O)-、-C(=O)O-、-C≡C-、-CH=CH-、-CH=N-及-N=CH-所組成之群中之至少1種基; R2 表示可具有聚合性基之烷基胺基、或可具有聚合性基之烷氧基; R3 表示選自由碳數4至20之烷二基、碳數2至20之烷二基氧基、碳數2至20之烷二基氧基羰基及碳數2至20之烷二基羰氧基所組成之群中之至少1種基; R4 表示聚合性基或氫原子; 於n為2之情形時,2個R1 可相同亦可不同,2個Ar2 可相同亦可不同]。A compound represented by the following formula (1); R 4 -R 3 -Ar 1 -(-R 1 -Ar 2 -) n -N=N-Ar 3 -R 2 (1) [in formula (1) , Ar 1 , Ar 2 and Ar 3 each independently represent a 1,4-phenylene group which may have a substituent or a divalent sulfur-containing aromatic heterocyclic group which may have a substituent, and at least one of Ar 1 and Ar 2 Has a fluorine atom as a substituent; n represents an integer of 1 or 2; R 1 represents a single bond, or is selected from -OC(=O)-, -C(=O)O-, -C≡C-, -CH= At least one group in the group consisting of CH-, -CH=N- and -N=CH-; R 2 represents an alkylamino group that may have a polymerizable group, or an alkoxy group that may have a polymerizable group; R 3 represents selected from the group consisting of alkanediyl groups having 4 to 20 carbon atoms, alkanediyloxy groups having 2 to 20 carbon atoms, alkanediyloxycarbonyl groups having 2 to 20 carbon atoms, and alkanediylcarbonyl groups having 2 to 20 carbon atoms At least one group in the group consisting of oxy; R 4 represents a polymerizable group or a hydrogen atom; when n is 2, two R 1 may be the same or different, and two Ar 2 may be the same or different ]. 如請求項1之化合物,其中上述式(1)中,Ar1 及Ar2 之任一者具有1個或2個氟原子作為取代基。The compound of claim 1, wherein in the above formula (1), any one of Ar 1 and Ar 2 has 1 or 2 fluorine atoms as a substituent. 如請求項1或2之化合物,其中上述式(1)中,R1 為單鍵。The compound of claim 1 or 2, wherein in the above formula (1), R 1 is a single bond. 如請求項1至3中任一項之化合物,其中上述式(1)中,n為1之整數。The compound according to any one of claims 1 to 3, wherein in the above formula (1), n is an integer of 1. 如請求項1至4中任一項之化合物,其中上述聚合性基為自由基聚合性基。The compound according to any one of claims 1 to 4, wherein the polymerizable group is a radical polymerizable group. 一種組合物,其包含如請求項1至5中任一項之化合物。A composition comprising the compound according to any one of claims 1 to 5. 一種膜,其以如請求項1至5中任一項之化合物作為形成材料。A film using the compound of any one of claims 1 to 5 as a forming material. 一種積層體,其包含如請求項7之膜。A laminate comprising the film as claimed in claim 7. 一種顯示裝置,其具備如請求項7之膜。A display device provided with a film as claimed in claim 7.
TW109124436A 2019-07-23 2020-07-20 Compound, composition, film, laminate, and display device TW202112738A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2019-135580 2019-07-23
JP2019135580 2019-07-23
JP2019-184055 2019-10-04
JP2019184055A JP7430506B2 (en) 2019-07-23 2019-10-04 Compounds, compositions, films, laminates and display devices

Publications (1)

Publication Number Publication Date
TW202112738A true TW202112738A (en) 2021-04-01

Family

ID=74563070

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109124436A TW202112738A (en) 2019-07-23 2020-07-20 Compound, composition, film, laminate, and display device

Country Status (2)

Country Link
JP (2) JP7368168B2 (en)
TW (1) TW202112738A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021014855A1 (en) 2019-07-23 2021-01-28 住友化学株式会社 Compound, composition, film, laminate, and display device
JP7368168B2 (en) 2019-07-23 2023-10-24 住友化学株式会社 Compounds, compositions, films, laminates and display devices
WO2021014856A1 (en) 2019-07-23 2021-01-28 住友化学株式会社 Composition, film, laminate, and display device
CN113929891B (en) * 2021-11-01 2023-01-13 宁波聚嘉新材料科技有限公司 High-strength liquid crystal polymer film, preparation method thereof and special production equipment

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010026024A (en) 2008-07-16 2010-02-04 Mitsubishi Chemicals Corp Composition for anisotropic film, anisotropic film, polarizing element, and azo compound
KR102073987B1 (en) 2012-02-28 2020-02-05 스미또모 가가꾸 가부시키가이샤 Compound and dichroic dye, and polarizing film
KR102087442B1 (en) 2012-03-26 2020-03-10 스미또모 가가꾸 가부시키가이샤 Mixture and method for producing the smae
CN104204933B (en) 2012-03-29 2017-04-26 富士胶片株式会社 Non-linear optical material and non-linear optical element using same
KR102147672B1 (en) 2014-05-26 2020-08-26 스미또모 가가꾸 가부시키가이샤 Composition
JP7362404B2 (en) 2019-07-23 2023-10-17 住友化学株式会社 Compositions, films, laminates and display devices
JP7368168B2 (en) 2019-07-23 2023-10-24 住友化学株式会社 Compounds, compositions, films, laminates and display devices

Also Published As

Publication number Publication date
JP7368168B2 (en) 2023-10-24
JP2021017541A (en) 2021-02-15
JP2021017540A (en) 2021-02-15
JP7430506B2 (en) 2024-02-13

Similar Documents

Publication Publication Date Title
JP7430506B2 (en) Compounds, compositions, films, laminates and display devices
JP7366681B2 (en) Compositions, films, laminates and display devices
TWI488846B (en) Polymerizable liquid crystal compounds and polymerizable liquid crystal compositions and alignment films
TWI521278B (en) Phase difference plate, display device having phase difference plate, and manufacturing method of phase difference plate
JP6473537B1 (en) Polymerizable liquid crystal compound, polymerizable composition, polymer, retardation film and manufacturing method thereof, transfer laminate, optical member and manufacturing method thereof, and display device
TW200848395A (en) Polymerizable optically active compound, and polymerizable composition containing the same
JP2023184545A (en) Composition, film, laminate, and display device
CN114144479B (en) Compound, composition, film, laminate, and display device
TWI521048B (en) A polymerizable liquid crystal compound, a polymerizable liquid crystal composition, and a alignment film
JP2022073664A (en) Compound, composition, film, laminate, and display device
TW202231646A (en) Azo compound, composition, film, laminate, and display device
JP7251197B2 (en) POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIC COMPOSITION, POLYMER, RETARDATION FILM AND MANUFACTURING METHOD THEREOF, LAMINATED TRANSFER, OPTICAL MEMBER AND MANUFACTURING METHOD THEREOF, AND DISPLAY DEVICE
TW202229516A (en) Composition, film, laminate, and display device
TW202311502A (en) Compound, composition, film, laminate, and display device
WO2023223639A1 (en) Polymerizable compound, polymerizable composition, optical film, and display apparatus
TW202306946A (en) Compound, composition, film, laminate, and display device
JP2022073665A (en) Compound, composition, film, laminate, and display device
JP2023031100A (en) Composition, compound, film, laminate and display unit